Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3008536	s-aspeag	— (—)	910	1944	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Influenza and pneumonia

489

324

9.36

315.03

2.3

2.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

477

361

8.85

309.46

2.1

2.3

—

ILD medications: prednisolone, methylprednisolone, prednisone

467

240

10.87

307.70

2.1

1.7

—

Liquid cancers, including Hilmo

377

193

17.54

307.65

3.3

1.4

—

Primary_lymphoid and hematopoietic malignant neoplasms

320

146

22.52

307.65

3.1

1.6

—

Transplanted organ and tissue status

258

52.73

307.65

4.1

1.5

—

Fever of other and unknown origin

366

278

11.51

307.65

2.7

1.9

—

ILD medications: immunosuppressive drugs

336

231

13.27

307.65

3.0

1.7

—

Pneumonia, organism unspecified

466

310

10.38

307.65

2.1

—

Pneumonias (Asthma/COPD co-morbidities)

498

319

10.26

307.65

2.1

2.2

—

Liquid cancers

364

162

21.76

307.65

3.3

1.4

—

All pneumoniae

492

340

9.46

307.65

2.1

2.3

—

431

214

11.85

307.10

2.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

431

214

11.85

307.10

2.1

—

Abnormal findings on diagnostic imaging of lung

338

297

10.90

305.72

2.1

2.0

—

Bacterial infection, other or unspecified

342

264

11.03

292.86

2.6

1.9

—

ILD medications

465

243

10.36

292.52

2.5

1.7

—

Bacterial infection, other or unspecified, including avohilmo

351

276

10.51

286.73

2.6

1.9

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

382

391

8.57

278.78

2.0

2.1

—

Other bacterial diseases

451

371

8.10

274.03

2.6

1.8

—

First line medication for Crohn's disease

430

250

9.30

253.72

2.3

2.1

—

L04AD Calcineurin inhibitors

175

21.60

233.92

3.2

2.0

—

Other bacterial diseases, including avohilmo

428

367

7.32

233.46

2.6

1.8

—

Aspergillosis, including avohilmo

114

171.77

230.71

3.0

1.7

—

Oral corticosteroids

435

367

6.98

221.22

1.9

2.5

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

421

445

6.41

214.01

2.5

1.9

—

Acute myeloid leukaemia and myelodysplastic syndromes

101

112.65

197.10

4.4

1.0

—

Asthma (only as main-diagnosis)

250

15.60

196.02

1.6

2.6

—

Inflammatory bowel disease treatment related agents

427

386

6.16

190.33

2.0

2.5

—

Septicaemia

226

207

10.04

189.72

2.8

1.8

—

Mycoses

212

10.13

187.43

2.6

2.1

—

Other septicaemia, including avohilmo

214

196

10.34

186.14

2.7

1.8

—

Failure and rejection of transplanted organs and tissues

92.46

185.96

6.1

1.6

—

Asthma (only as main-diagnosis), excluding more controls

237

15.13

182.09

1.6

2.7

—

Myeloid leukaemia

104

54.85

181.95

4.0

1.3

—

Other septicaemia

208

192

10.30

180.96

2.7

1.8

—

Asthma

245

14.10

173.83

1.6

2.6

—

Asthma, excluding more controls

238

14.10

168.33

1.6

2.7

—

Bacterial pneumonia (organism specified)

226

256

8.05

160.32

2.0

2.3

—

Asthma, unspecified (mode)

175

14.75

160.15

1.6

2.6

—

Bronchiectasis

107

29.06

159.96

1.4

—

Bacterial pneumoniae

185

152

10.76

159.69

1.9

2.0

—

Asthma and opportunity respiratory infection

102

31.71

156.07

1.8

1.5

—

Explicit Sepsis, including avohilmo

238

299

7.27

154.97

2.7

1.8

—

Asthma, unspecified (mode), excluding more controls

170

14.72

154.54

1.6

2.7

—

Other diseases of blood and blood-forming organs, wide

171

167

10.39

153.83

3.1

1.9

—

Asthma-related pneumonia

207

262

7.94

151.57

1.6

2.4

—

Asthma-related pneumonia or sepsis

207

262

7.94

151.56

1.6

2.4

—

Asthma, hospital admissions 3, pneumonia

207

262

7.94

151.56

1.6

2.4

—

Explicit Sepsis

232

295

7.22

150.42

2.7

1.8

—

ILD, hospital admission 2, with pulmonary infections

34.27

148.14

1.7

1.3

—

Bacterial pneumonia, not elsewhere classified

172

144

10.56

146.69

1.8

2.0

—

Asthma (mode)

215

12.45

146.35

1.6

2.6

—

ILD, hospital admissions 3, with pneumonia sepsis

37.51

142.13

1.7

1.3

—

Non-Hodgkin lymphoma, all, including Hilmo

110

17.49

134.37

2.9

1.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

351

460

4.84

131.96

3.3

1.4

—

Infections, IBD-co-morbidities

129

18.74

128.20

3.2

2.4

—

Asthma-related infections

252

454

5.44

127.49

1.6

2.5

—

Asthma, hospital admission 2, infections

252

454

5.44

127.49

1.6

2.5

—

Fungal Sepsis

31.39

123.69

3.3

1.5

—

Agranulocytosis

106

14.82

118.71

3.2

1.6

—

Implicit fungal Sepsis

32.28

118.55

3.4

1.5

—

COPD/asthma related infections

271

214

6.36

117.78

2.2

2.1

—

COPD/asthma/ILD related infections

271

214

6.36

117.78

2.2

2.1

—

Lymphoid leukaemia

21.02

117.41

2.6

1.5

—

Early onset COPD, excluding more controls

21.65

115.78

1.7

2.2

—

Aspergillosis

114

193.13

114.82

3.0

1.7

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

102

14.90

114.49

5.8

1.5

—

Malignant neoplasm

281

306

5.40

114.35

3.3

1.4

—

Malignant neoplasm, including Hilmo

282

306

5.39

114.21

3.3

1.3

—

Malignant neoplasm

280

305

5.40

113.90

3.3

1.4

—

Malignant neoplasm, wide definition

279

310

5.26

110.32

3.3

1.4

—

Viral pneumonia

19.36

110.27

2.4

1.8

—

Anaemias

111

22.39

109.71

3.3

1.2

—

All influenza

118

110

10.81

109.49

2.7

2.2

—

Myelodysplastic syndrome, including Hilmo

51.02

108.89

4.2

1.0

—

Rare circulating lymphoid malignancy, including Hilmo

58.42

108.24

2.9

1.1

—

Pneumonia due to other infectious organisms, not elsewhere classified

56.99

106.06

2.6

1.6

—

Implicit fungal Sepsis, including avohilmo

19.99

103.68

3.3

1.4

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

101

20.55

103.52

1.7

2.5

—

Other pulmonary diagnosis

178

9.72

103.40

2.3

2.6

—

Bacterial Sepsis

204

295

5.75

102.80

2.5

1.7

—

Any death

258

372

4.88

102.14

2.2

2.1

—

Certain infectious and parasitic diseases

237

190

6.26

101.82

2.4

1.5

—

L04AA Selective immunosuppressants

142

186

7.72

101.62

2.6

2.3

—

Excluding asthma or asthma-COPD overlap

176

9.61

101.58

2.3

2.6

—

COPD differential diagnosis

175

9.66

101.32

2.3

2.6

—

ILD differential diagnosis

175

9.66

101.31

2.3

2.6

—

Chronic lower respiratory diseases

353

478

3.90

95.67

1.7

2.6

—

Other respiratory diseases principally affecting the interstitium

119

137

8.80

94.74

1.6

1.9

—

Any event in cancer register

269

344

4.58

92.26

3.2

1.5

—

COPD (mode)

14.89

91.94

1.6

2.2

—

Dental caries

135

176

7.30

89.88

2.9

2.1

—

Asthma (diagnoses ohter than nonallergic)

285

600

3.85

88.97

1.5

2.4

—

Other interstitial pulmonary diseases

108

123

8.90

86.76

1.6

1.8

—

Interstitial lung disease

108

124

8.83

86.21

1.6

1.8

—

Interstitial lung disease endpoints

108

124

8.83

86.21

1.6

1.8

—

Implicit bacterial Sepsis

172

266

5.57

85.30

2.5

1.7

—

Implicit bacterial Sepsis, including avohilmo

181

287

5.27

83.68

2.4

1.7

—

GASTRO-related operations

174

122

7.17

83.21

2.7

1.2

—

Any gastric operation

174

122

7.17

83.21

2.7

1.2

—

Asthma, hospital admissions , main diagnosis only

264

605

3.81

83.13

1.6

2.4

—

ILD, hospital admissions

106

125

8.60

82.85

1.6

1.8

—

General symptoms and signs

276

321

4.32

82.81

2.5

1.8

—

174

340

5.10

82.68

1.6

2.7

—

Asthma/COPD (KELA code 203)

274

473

3.88

81.18

1.5

2.6

—

Non-Hodgkin lymphoma, all

29.23

80.71

3.3

1.0

—

Allergic asthma (mode)

17.28

80.39

1.6

3.1

—

Caries of dentine

118

155

7.40

80.32

3.0

2.1

—

Undetermined asthma

27.18

79.04

1.5

3.7

—

Cytomegalovirus infection, IBD co-morbidity

30.63

78.40

4.2

1.5

—

Allergic asthma (mode), excluding more controls

16.42

78.39

1.6

3.0

—

Other diseases of pleura

184

334

4.81

78.08

2.0

—

Undetermined asthma, excluding more controls

25.89

77.71

1.5

3.6

—

Non-follicular lymphoma

11.00

75.71

2.3

1.9

—

Cytomegaloviral disease

27.49

75.64

4.2

1.5

—

Cytomegaloviral disease, including avohilmo

27.47

75.63

4.2

1.5

—

Implicit viral Sepsis

101

126

8.08

75.33

2.8

1.8

—

Viral Sepsis

101

126

8.08

75.33

2.8

1.8

—

Oxycodone

164

275

5.13

74.35

2.6

2.0

—

Mycoses, including avohilmo

281

623

3.44

73.51

2.4

2.0

—

Certain disorders involving the immune mechanism

109

153

7.20

73.47

2.2

—

Chronic lymphocytic leukaemia, helper endpoint

36.78

73.43

2.0

1.0

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

36.78

73.43

2.0

1.0

—

Chronic lymphocytic leukaemia

36.78

73.43

2.0

1.0

—

Acute myeloid leukaemia, helper endpoint

175.41

73.18

4.4

1.0

—

Acute myeloid leukaemia

175.41

73.18

4.4

1.0

—

Acute myeloid leukaemia, including Hilmo

175.41

73.18

4.4

1.0

—

Non-allergic asthma (mode), excluding more controls

16.88

73.01

1.6

2.8

—

Non-allergic asthma (mode)

16.88

73.00

1.6

2.8

—

Any reimbursement code in KELA

122

10.05

72.35

2.6

1.4

—

ILD, hospital admissions 1, main diag only

116

8.31

72.23

1.6

1.8

—

Other medical care

181

332

4.60

71.93

2.1

2.3

—

Aplastic and other anaemias

181

383

4.35

69.10

2.8

1.8

—

Complications of surgical and medical care, not elsewhere classified

285

571

3.34

68.28

3.1

1.7

—

Complications of medical and surgical care

231

577

3.61

68.12

3.3

1.7

—

Other acute lower respiratory infections

190

444

4.09

67.95

2.2

—

Diffuse large B-cell lymphoma, including Hilmo

23.40

66.27

2.2

1.0

—

Diffuse large B-cell lymphoma, helper endpoint

23.40

66.27

2.2

1.0

—

Diffuse large B-cell lymphoma

23.40

66.27

2.2

1.0

—

279

399

3.55

66.11

2.3

2.0

—

Other/unspecified cytomegaloviral diseases

28.10

65.83

4.5

1.6

—

Secondary uncertain malignant neoplasm

11.24

65.69

2.6

1.2

—

Secondary and unspecified malignant neoplasm of lymph nodes

14.17

65.62

2.7

1.3

—

Persons encountering health services for specific procedures and health care

288

518

3.29

64.73

2.1

2.3

—

Provisional assignment of new diseases of uncertain etiology

181

445

4.05

64.62

2.0

2.2

—

Codes for special purposes

181

445

4.05

64.61

2.0

2.2

—

Enlarged lymph nodes

9.35

64.47

2.6

1.9

—

COPD

150

248

4.93

64.04

1.7

2.4

—

Implicit Sepsis

220

436

3.73

63.98

2.3

1.8

—

Covid-19 confirmed case

145

306

4.76

63.72

1.9

2.0

—

Pneumocystosis, including avohilmo

23.37

62.76

2.7

1.5

—

Pneumocystosis

23.37

62.76

2.7

1.5

—

Haemorrhage from respiratory passages

130

218

5.30

62.07

1.9

2.4

—

Neoplasms

177

195

4.77

60.71

3.2

1.4

—

Implicit viral Sepsis, including avohilmo

114

205

5.58

60.03

2.7

1.7

—

Other chronic obstructive pulmonary disease

141

238

4.87

59.52

1.6

2.4

—

Acute bronchitis

146

321

4.48

59.33

2.3

2.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

194

525

3.64

59.33

3.7

1.7

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

117

178

5.67

59.14

1.7

1.9

—

Acute sinusitis

166

369

4.10

58.87

2.2

2.1

—

Bronchitis

287

559

3.09

58.81

2.4

2.0

—

Diseases of the respiratory system

119

7.47

58.72

2.0

2.4

—

Purpura and other haemorrhagic conditions

101

7.91

57.80

3.4

2.0

—

Other and unspecified anaemias

156

352

4.18

57.20

2.7

1.8

—

Other anaemias

156

356

4.12

56.09

2.7

1.8

—

Nephropathy related operations

102

7.75

56.03

2.2

1.9

—

Implicit Sepsis, including avohilmo

220

462

3.41

55.79

2.3

1.8

—

Immunodeficiencies

16.59

55.68

2.0

1.4

—

Protozoal diseases

15.47

55.64

2.6

1.4

—

Protozoal diseases, including avohilmo

15.44

55.62

2.6

1.4

—

Dialysis, with operation codes

109

7.43

55.45

2.2

2.0

—

Chronic sinusitis

143

336

4.27

54.98

1.5

2.5

—

L01XX Other antineoplastic agents

12.89

54.71

2.5

1.4

—

Asthma, including avohilmo

304

579

2.90

54.54

1.6

2.5

—

Certain infectious and parasitic diseases, including avohilmo

140

129

5.45

53.56

2.3

1.5

—

Thrombocytopenia, unspecified

10.53

53.55

3.1

1.6

—

Drug-induced neutropenia

10.36

52.04

3.0

1.6

—

ILD medications: azathioprine

12.22

51.28

1.5

1.4

—

19.86

51.24

1.6

1.5

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

8.14

50.32

2.6

1.3

—

Condition for Implicit Sepsis (Organ dysfunction codes)

215

462

3.23

49.78

2.3

1.8

—

Coagulation defects, purpura and other haemorrhagic conditions

160

5.73

49.33

3.6

2.1

—

COPD, hospital admission 2, with asthma infections

122

230

4.59

49.00

1.7

2.1

—

Viral infections characterized by skin and mucous membrane lesions

145

379

3.84

48.33

2.3

2.2

—

Candidiasis

7.24

48.20

2.3

1.8

—

Other diseases of the respiratory system

157

5.71

48.09

2.1

—

Other respiratory disorders and diseases

157

5.71

48.09

2.1

—

Cough

123

268

4.30

46.83

1.8

2.4

—

Second line medication for Crohn's disease

175

533

3.29

46.25

2.2

2.1

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

214

467

3.10

46.03

2.3

1.9

—

L04AX Other immunosuppressants

171

521

3.29

45.22

2.2

—

Other viral diseases

106

235

4.52

43.84

3.3

2.4

—

Candidiasis, including avohilmo

205

4.75

42.79

2.1

1.9

—

Later onset COPD, excluding more controls

11.96

42.57

1.4

1.7

—

Abnormalities of breathing

203

370

3.14

42.37

1.9

2.4

—

Heart failure, not strict

207

465

3.00

42.17

2.0

2.2

—

Unspecified acute lower respiratory infection

111

6.36

42.17

1.9

2.2

—

All influenza (not pneumonia)

9.66

42.09

2.4

2.2

—

All kidney diseases

244

603

2.72

41.66

2.3

2.1

—

Enterocolitis due to Clostridium difficile

7.51

40.68

3.2

1.4

—

COPD, early/later onset

142

335

3.57

40.66

1.6

2.0

—

Renal tubulo-interstitial diseases

223

590

2.77

40.64

2.2

2.1

—

COPD-related respiratory insufficiency

6.89

38.96

1.8

1.5

—

COPD, hospital admissions

139

335

3.51

38.84

1.6

2.0

—

Other viral diseases, including avohilmo

116

302

3.82

38.39

3.1

2.3

—

Bleeding

217

557

2.74

38.15

2.1

2.2

—

COPD, hospital admissions 1, only main diagnosis

115

252

3.94

38.11

1.6

1.9

—

Chronic kidney disease

111

272

3.94

38.11

1.8

1.9

—

Bacterial intestinal infections, IBD co-morbidities

137

5.44

38.03

3.0

1.9

—

Pulmonary heart disease, diseases of pulmonary circulation

107

269

4.00

37.82

2.4

1.9

—

Renal failure

151

399

3.23

37.35

2.1

1.9

—

Other bacterial intestinal infections

140

5.32

37.15

3.0

1.9

—

Dyspnoea

223

611

2.64

36.88

1.7

2.2

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

9.46

36.86

2.5

2.4

—

Asthma and allergy, excluding more controls

14.87

36.82

1.5

3.5

—

Asthma and allergy

14.86

36.81

1.5

3.5

—

Other chronic obstructive pulmonary disease, including avohilmo

157

411

3.15

36.77

1.5

2.2

—

Acute upper respiratory infections of multiple and unspecified sites

185

466

2.90

36.57

2.5

2.0

—

Lung cancer and mesothelioma

11.63

36.55

1.6

1.8

—

Other disorders of white blood cells

10.43

36.05

2.7

1.3

—

Early onset COPD

190

4.56

36.03

1.7

2.4

—

Acute upper respiratory infections

238

552

2.59

35.99

2.5

1.9

—

All chronic kidney diseases

160

415

3.08

35.95

2.0

2.1

—

Examination and observation for other reasons

134

203

3.73

35.73

1.9

2.1

—

Infection due to other mycobacteria

49.83

35.15

1.6

1.4

—

Viral pneumonia (known virus, not influenza)

14.29

34.89

2.9

1.6

—

Pulmonary embolism

238

4.05

34.62

2.5

2.0

—

Infection due to other mycobacteria, including avohilmo

44.70

34.43

1.6

1.4

—

COPD related to multimorbidity

121

290

3.54

34.36

1.6

1.9

—

L01XE Protein kinase inhibitors

9.28

33.95

3.3

1.5

—

Pulmonary heart disease

242

3.99

33.85

2.5

2.0

—

Lung transplantation

51.51

33.81

1.8

—

Obesity related asthma

102

269

3.81

33.78

1.1

2.6

—

Erysipelas

117

285

3.55

33.57

1.7

1.8

—

Azathioprine

6.93

33.43

1.5

2.5

—

ILD-related respiratory insufficiency

11.21

32.98

1.3

1.5

—

Osteopathies and chondropathies

154

481

2.93

32.98

2.2

—

Lung transplant status

50.08

32.81

1.8

—

Solid cancers, including Hilmo

161

306

3.07

32.73

2.7

1.4

—

DVT of lower extremities and pulmonary embolism

123

373

3.30

32.71

2.6

1.9

—

Solid cancers

159

303

3.08

32.57

2.8

1.4

—

Leukaemia of unspecified cell type

48.45

32.57

3.6

1.7

—

Medical observation and evaluation for suspected diseases and conditions

139

205

3.47

32.37

2.5

2.1

—

Myeloproliferative diseases

7.51

32.24

3.7

1.5

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

217

686

2.47

32.00

2.3

2.1

—

Emphysema

9.36

31.81

2.1

1.6

—

Venous thromboembolism

146

485

2.91

31.16

2.5

2.0

—

Respiratory insufficiency

39.29

31.13

1.5

1.4

—

Other bacterial intestinal infections, including avohilmo

189

4.25

30.82

2.8

1.9

—

Erysipelas, including avohilmo

137

327

3.11

30.71

1.6

1.8

—

Idiopathic pulmonary fibrosis

7.23

30.52

1.4

1.5

—

Explicit bacterial Sepsis

6.77

30.10

2.3

1.9

—

Zoster [herpes zoster]

157

4.55

29.77

2.6

1.9

—

Myelodysplastic syndrome

53.53

29.76

4.7

1.0

—

Explicit bacterial Sepsis, including avohilmo

6.67

29.70

2.3

1.9

—

Symptoms and signs involving the circulatory and respiratory systems

196

370

2.66

29.58

2.2

2.4

—

Atypical mycobacterium lung infection

34.42

29.57

1.7

1.5

—

Malaise and fatigue

105

233

3.55

29.49

2.1

1.8

—

General examination and investigation of persons without complaint and reported diagnosis

132

205

3.35

29.44

2.4

2.1

—

Diagnoses used for exclusion with ILD

219

3.90

29.16

1.7

2.1

—

Other metabolic disorders

103

5.48

29.06

4.1

1.9

—

Systemic connective tissue disorders

101

295

3.44

28.81

1.9

2.0

—

Streptococcal septicaemia

7.98

28.12

2.5

1.8

—

Multiple myeloma and malignant plasma cell neoplasms

8.90

28.09

2.8

1.6

—

Pleural effusion

110

5.22

28.06

1.8

1.9

—

Intestinal infectious diseases

216

689

2.33

28.03

2.2

2.1

—

Care involving dialysis

7.07

27.97

1.4

2.3

—

Streptococcal septicaemia, including avohilmo

7.82

27.64

2.5

1.8

—

Herpesviral [herpes simplex] infections

5.88

27.39

2.4

2.1

—

Opioids

191

388

2.55

26.88

2.3

2.1

—

Suggestive for eosinophilic asthma

6.90

25.44

1.4

2.3

—

Viral pneumonia (unknown virus, not influenza)

8.33

25.25

2.4

2.5

—

Heart failure,strict

136

340

2.80

25.08

1.7

2.2

—

Osteoporosis

203

3.68

25.08

1.7

—

Other diseases of upper respiratory tract

229

531

2.25

24.94

2.0

2.3

—

Suppurative and necrotic conditions of lower respiratory tract

7.08

24.61

2.4

1.7

—

Factors influencing health status and contact with health services

5.80

24.54

2.1

1.4

—

Other and unspecified disorders of white blood cells

9.81

24.15

3.2

1.3

—

Gout, FINNGEN

258

3.36

24.02

2.1

1.8

—

Zoster [herpes zoster], including avohilmo

128

460

2.69

23.82

2.5

2.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

229

555

2.19

23.72

2.0

2.2

—

Cardiovascular diseases (excluding rheumatic etc)

127

250

2.91

23.66

2.5

2.3

—

Acute renal failure

188

3.79

23.52

2.6

1.9

—

Other heart diseases

105

218

3.14

23.07

2.3

—

Multiple myeloma, including Hilmo

20.35

23.03

2.8

1.5

—

Autoimmune diseases related-to ILD

175

635

2.30

22.77

2.0

2.2

—

Tramadol

153

368

2.50

21.94

1.9

2.1

—

Metabolic disorders

206

568

2.18

21.73

2.5

2.1

—

Non-invasive ventilation

140

3.96

21.59

2.5

2.6

—

Immunodeficiency with predominantly antibody defects

19.38

21.37

1.8

1.6

—

Dermatitis

142

575

2.42

21.34

2.4

2.1

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

4.92

21.29

4.6

1.8

—

Sarcoidosis

106

4.65

21.20

1.8

2.3

—

Pneumothorax

7.02

21.20

1.8

1.6

—

Complications of procedures, not elsewhere classified

160

558

2.31

20.89

1.6

1.7

—

4.92

20.81

2.5

2.4

—

Gout

239

3.14

20.74

2.1

2.3

—

Other and unspecified dermatitis

124

490

2.54

20.71

2.4

2.1

—

Polyarthropathies

156

423

2.37

20.41

2.2

2.3

—

Other necrotizing vasculopathies

6.73

20.40

2.1

1.5

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

7.55

20.40

4.1

1.6

—

Myeloproliferative diseases (CML excluded)

6.24

20.19

3.6

1.5

—

Nutritional anaemias

116

429

2.58

19.94

1.9

2.0

—

Diseases of oesophagus, stomach and duodenum

213

607

2.07

19.85

2.0

2.2

—

Oedema, not elsewhere classified

182

3.55

19.83

1.8

—

Autoimmune diseases excluding thyroid diseases, strict definition

207

536

2.10

19.57

2.1

2.3

—

Other necrotizing vasculopathies (FG)

7.79

19.56

1.9

1.3

—

Autoimmune diseases excluding thyroid diseases

210

548

2.08

19.28

2.1

2.3

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

112

4.31

18.93

2.1

2.0

—

Tuberculosis, wide, including avohilmo

6.38

18.82

1.5

1.6

—

Heart failure, strict

139

406

2.38

18.80

1.7

2.2

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

24.16

18.69

2.8

1.0

—

Multiple myeloma

24.16

18.69

2.8

1.0

—

Tuberculosis, IBD comorbidity

6.80

18.68

1.5

1.4

—

Persons encountering health services in other circumstances, wide

219

555

2.03

18.65

2.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

147

583

2.25

18.54

2.0

2.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

112

205

2.77

18.52

2.4

2.1

—

Other infectious diseases

5.72

18.51

4.0

1.5

—

Symptoms and signs involving the skin and subcutaneous tissue

154

665

2.19

18.31

2.1

—

Hernia of abdominal wall, postoperative

5.64

18.29

1.6

1.2

—

Diseases of the skin and subcutaneous tissue

183

425

2.16

18.16

2.4

2.2

—

Chronic rhinitis, nasopharyngitis and pharyngitis

250

3.05

18.02

1.5

2.5

—

Dermatitis and eczema

222

670

1.96

17.93

2.2

2.1

—

Codeine

159

381

2.26

17.84

2.0

2.1

—

Cystic fibrosis with pulmonary manifestations

+∞

17.76

1.3

0.0

—

Inflammatory diseases of the central nervous system

5.34

17.76

1.5

2.3

—

Extracorporeal dialysis

5.46

17.61

1.5

—

Kidney transplant status

5.92

17.45

1.7

1.8

—

All-cause Heart Failure

134

401

2.33

17.26

1.7

2.1

—

Heart failure and antihypertensive medication

156

3.18

17.12

1.9

2.4

—

Dermatitis due to substances taken internally

6.91

16.98

2.0

—

Other pleural conditions

4.96

16.86

1.8

1.5

—

Tuberculosis, wide

5.96

16.50

1.5

1.6

—

Cardiovascular diseases

109

222

2.61

16.47

2.7

2.4

—

Cystic fibrosis with intestinal manifestations

+∞

16.46

1.3

0.0

—

Other infectious diseases, including avohilmo

4.83

16.35

3.8

1.6

—

Abnormal findings on examination of blood, without diagnosis

115

441

2.36

16.30

2.0

2.1

—

Headache

293

2.59

16.22

1.7

1.8

—

Polyneuropathies and other disorders of the peripheral nervous system

194

3.21

16.06

2.7

2.1

—

Osteonecrosis

5.61

16.02

3.0

1.7

—

Continuous positive airway pressure

114

3.74

15.85

1.9

2.4

—

Other heart diseases, wide

173

512

2.05

15.81

2.4

2.2

—

Acute generalized exanthematous pustulosis

7.27

15.69

2.2

2.1

—

Hypothyroidism and >3 levothyroxin purchases

5.95

15.58

2.2

1.2

—

Hypothyroidism, levothyroxine purchases

5.95

15.58

2.2

1.2

—

Hypothyroidism (congenital or acquired)

5.95

15.56

2.2

1.2

—

Iron deficiency anaemia

373

2.50

15.52

1.8

2.0

—

Tuberculosis

6.24

15.47

1.3

1.6

—

Intestinal infectious diseases, including avohilmo, including avohilmo

218

646

1.88

15.40

2.2

2.1

—

Other disorders of skin and subcutaneous tissue

149

607

2.07

15.21

1.9

2.2

—

Herpesviral [herpes simplex] infections, including avohilmo

192

3.13

14.99

2.3

—

Heart failure and bmi 25plus

190

2.81

14.93

1.7

2.3

—

Budesonide

4.87

14.70

3.8

2.6

—

Chronic myeloproliferative disease

14.76

14.68

4.4

1.4

—

Pain in throat and chest

134

361

2.20

14.62

1.9

2.4

—

Persons encountering health services for examination and investigation

103

205

2.52

14.39

2.4

2.1

—

Other systemic involvement of connective tissue (FG)

198

3.03

14.37

1.7

2.0

—

Atrial fibrillation and flutter

145

3.03

14.30

2.1

2.4

—

Disorders of lens

145

429

2.10

14.29

2.1

2.2

—

Other systemic involvement of connective tissue

222

2.89

13.94

1.9

—

Finngen Rheumatological endpoints

173

502

1.96

13.86

2.5

2.3

—

Ethmoidectomy

3.96

13.84

1.5

2.5

—

FESS (DNB20)

4.02

13.77

1.5

2.3

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

116

3.48

13.76

1.5

1.3

—

Noninfective enteritis and colitis

101

440

2.30

13.76

2.1

2.3

—

Respiratory tuberculosis

6.27

13.74

1.3

1.5

—

Respiratory tuberculosis, confirmed and not-confirmed

6.27

13.74

1.3

1.5

—

Covid-19 suspected case

147

3.34

13.63

2.4

2.5

—

Gastrointestinal diseases

166

2.66

13.62

2.4

2.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

195

2.65

13.58

2.9

2.3

—

Donors of organs and tissues

26.42

13.43

3.3

2.1

—

Other noninfective gastroenteritis and colitis

222

2.84

13.33

2.1

2.2

—

Osteoporosis with pathological fracture (FG)

6.32

13.28

1.2

1.7

—

Pain in limb

162

530

1.94

13.11

1.8

2.3

—

Infections of the skin and subcutaneous tissue

122

576

2.09

13.10

2.2

—

Abnormal findings on diagnostic imaging of central nervous system

10.10

12.97

1.8

1.6

—

Other viral diseases, not elsewhere classified

152

3.22

12.86

2.3

2.2

—

Other skin changes

179

3.03

12.78

2.4

1.8

—

Mature T/NK-cell lymphomas, hilmo

15.96

12.71

3.8

1.3

—

Non-ischemic cardiomyopathy

248

2.53

12.70

1.8

2.1

—

Diseases of liver

339

2.43

12.66

1.8

2.3

—

Nonhereditary hypogammaglobulinemia

20.84

12.56

1.7

—

Other diseases of intestines

193

590

1.82

12.52

2.1

2.3

—

Other and unspecified polyneuropathies, also in other diseases

172

3.04

12.36

2.4

2.2

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

5.17

12.28

1.6

1.3

—

Simple and mucopurulent chronic bronchitis

10.57

12.25

1.4

1.6

—

Other and unspecified immunodeficiencies with predominantly antibody defects

16.44

12.24

2.2

1.6

—

Sequelae of external causes of morbidity and mortality

233

2.71

12.23

2.9

2.0

—

Persons encountering health services for specific procedures, not carried out

4.93

12.14

1.3

2.5

—

Cardiac arrhythmias

108

315

2.20

12.14

2.3

—

Care involving use of rehabilitation procedures

109

464

2.11

11.97

2.2

2.3

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

4.84

11.89

2.4

1.4

—

Disorders of other endocrine glands

392

2.26

11.88

2.1

—

Kela reimbursement Agammaglobulinemia (D80-84)

19.83

11.71

2.5

1.8

—

Other reaction to severe stress, and adjustment disorders

280

2.50

11.60

2.4

2.5

—

Pain, not elsewhere classified

148

3.11

11.47

2.3

1.8

—

Other mycoses, not elsewhere classified/unspecified

22.20

11.41

3.1

1.8

—

Sequelae with surgical and medical care as external cause

175

2.92

11.40

2.9

2.0

—

Other problems related to primary support group, including family circumstances

4.41

11.38

2.3

2.6

—

Childhood asthma (age<16)

10.00

11.34

2.0

3.6

—

Childhood asthma (age<16), excluding more controls

10.00

11.34

2.0

3.6

—

Follicular lymphoma, hilmo

5.59

11.18

2.0

1.5

—

Disorders of oesophagus in diseases classified elsewhere

12.93

11.17

1.7

1.8

—

Nausea and vomiting

216

2.67

11.10

1.7

2.1

—

Drug-induced cataract

10.21

11.04

4.3

1.5

—

Glomerular diseases

157

3.00

11.03

1.5

2.2

—

Hypertensive diseases (excluding secondary)

210

2.36

10.94

1.9

2.3

—

Other disorders of lacrimal gland

338

2.31

10.90

2.4

2.1

—

Other viral diseases, not elsewhere classified, including avohilmo

218

2.65

10.81

2.3

2.4

—

Sulfasalazine

138

3.12

10.79

2.3

2.9

—

Abnormal findings on diagnostic imaging of other body structures

3.96

10.73

2.7

1.8

—

Other mycoses, not elsewhere classified/unspecified, including avohilmo

13.15

10.69

2.8

1.6

—

Symptoms and signs concerning food and fluid intake

4.71

10.66

1.3

1.9

—

Depression medications

4.73

10.62

2.7

1.2

—

Other and unspecified disorders of skin and subcutaneous tissue

5.28

10.58

2.7

1.3

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

8.60

10.56

4.1

1.7

—

Other and unspecified iron deficiency

287

2.40

10.53

1.7

1.9

—

Reimbursement for rheumatic diseases

108

538

2.00

10.43

2.2

2.1

—

Diseases of the digestive system

445

2.10

10.39

2.1

—

Bronchitis, not specified as acute or chronic

4.91

10.25

2.6

2.8

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

4.55

10.23

1.7

1.4

—

Malignant neoplasm of respiratory system and intrathoracic organs

107

3.19

10.16

1.3

—

Other disorders involving the immune mechanism, not elsewhere classified

7.98

10.12

4.1

1.6

—

Senile cataract

126

396

1.94

10.12

1.8

2.2

—

Bacterial, viral and other infectious agents, including avohilmo

3.89

10.11

3.3

2.1

—

Abscess of lung

10.28

10.07

3.2

1.4

—

Cardiomyopathy

139

3.03

10.03

1.6

2.3

—

Dialysis

4.84

10.02

1.3

1.5

—

Nasal polyp

145

2.97

9.96

1.3

2.4

—

Malignant neoplasm of skin, including Hilmo

223

2.31

9.94

1.8

1.4

—

Generalized skin eruption due to drugs and medicaments

7.68

9.90

2.2

1.6

—

Noninfectious colitis NAS

100

3.41

9.84

2.9

2.2

—

Disorders of lacrimal system

399

2.12

9.80

2.5

2.0

—

Preparatory care for dialysis

4.93

9.79

1.1

1.4

—

Visual disturbances

466

2.04

9.79

1.9

2.0

—

Other complications of surgical and medical care, not elsewhere classified

4.38

9.78

1.6

1.5

—

Later onset COPD

172

2.62

9.77

1.5

1.7

—

Bacterial, viral and other infectious agents

3.86

9.66

3.4

2.2

—

Secondary right heart disease

5.33

9.64

1.6

1.4

—

Other pulmonary heart/vessel disease

5.04

9.57

1.5

1.6

—

Syncope and collapse

222

2.41

9.51

1.7

1.8

—

Malignant neoplasm of bronchus and lung, including Hilmo

108

3.10

9.50

1.6

1.3

—

Paroxysmal tachycardia

130

2.88

9.45

1.8

2.5

—

Recurrent aphthous stomatitis , including avohilmo

119

3.12

9.31

2.6

2.0

—

Abnormal results of function studies

4.69

9.28

1.3

2.2

—

Gout, idiopatic and unspecified

232

2.46

9.23

1.7

2.0

—

Visual disturbances and blindness

100

511

1.96

9.19

1.9

2.1

—

Autoimmune diseases

184

553

1.69

9.18

2.3

—

Polycythaemia vera

13.77

9.18

3.1

1.0

—

Codeine or tramadol medication

189

616

1.67

9.13

1.9

2.2

—

Symptoms and signs involving the digestive system and abdomen

170

494

1.73

9.12

2.3

2.2

—

Disorders of eyelid, lacrimal system and orbit

154

654

1.73

9.00

2.3

2.1

—

Chronic myeloid leukaemia, including Hilmo

24.77

8.97

4.0

1.0

—

Parasetamol

112

289

1.96

8.95

2.2

2.4

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

444

2.00

8.94

1.9

2.4

—

Gastro-oesophageal reflux disease

122

562

1.83

8.93

1.7

2.2

—

Other disorders of fluid, electrolyte and acid-base balance

279

2.27

8.92

2.0

1.9

—

Use of hypnotics and sedatives

185

638

1.66

8.87

1.9

2.1

—

Other soft tissue disorders, not elsewhere classified

163

541

1.71

8.83

1.8

2.3

—

Pyothorax

4.69

8.83

1.6

1.5

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

8.64

8.79

2.3

1.4

—

Dysphagia

202

2.53

8.76

1.6

2.0

—

Stomatitis and related lesions

162

2.72

8.73

2.7

2.4

—

6-mercaptopurine

14.11

8.69

3.1

1.7

—

Iron deficiency anaemia secondary to blood loss (chronic)

119

3.03

8.67

2.1

1.8

—

Neurological diseases, wide definition

3.17

8.65

2.1

2.5

—

Sicca syndrome [Sjögren]

4.39

8.61

1.3

1.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

207

2.25

8.45

1.7

1.4

—

Drug-induced osteoporosis

13.05

8.42

1.2

1.6

—

Localized swelling, mass and lump of skin and subcutaneous tissue

293

2.22

8.39

2.3

2.2

—

Other and unspecified aplastic anaemias

11.05

8.35

4.6

1.5

—

Respiratory disorders in diseases classified elsewhere

10.99

8.34

2.1

1.5

—

Chronic apical periodontitis

185

637

1.63

8.30

2.4

2.1

—

Used for control exclusion in common control thyroid runs

171

516

1.67

8.26

2.4

2.3

—

Chronic gastritis

208

2.46

8.26

2.0

1.9

—

Rheumatoid arthritis

248

2.25

8.21

2.3

2.2

—

Other encephalitis

7.60

8.17

1.4

1.5

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

169

658

1.65

8.16

2.1

—

Gout, unspecified

180

2.56

8.13

1.7

1.8

—

Mantle cell lymphoma, including Hilmo

17.50

8.10

2.9

1.0

—

Cellulitis

198

2.48

8.10

2.0

2.3

—

Glomerulonephritis

3.39

8.06

1.4

1.9

—

Persons encountering health services in other circumstances

327

2.12

8.05

1.9

2.3

—

Encephalitis

7.29

7.97

1.4

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

7.77

7.87

1.5

—

Non-small cell lung cancer, including Hilmo

3.43

7.82

1.7

1.2

—

Biological medicines for asthma

10.92

7.81

1.4

1.6

—

Other immunodeficiencies

15.38

7.75

2.1

1.4

—

Fentanyl

3.64

7.70

1.9

2.1

—

Nonsuppurative otitis media

143

2.61

7.69

2.1

2.5

—

GI-bleeding

285

2.18

7.66

2.2

2.1

—

Diseases of middle ear and mastoid

423

1.87

7.65

2.1

2.3

—

Gastroduodenal ulcer

191

2.46

7.64

1.6

2.0

—

Seropositive rheumatoid arthritis

197

2.43

7.60

1.8

2.0

—

Wegener granulomatosis

9.03

7.58

1.7

1.5

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

6.16

7.53

1.7

1.3

—

Acute tubulo-interstitial nephritis

102

471

1.83

7.51

1.8

2.0

—

Vocal cord dysfunction

3.65

7.47

1.3

3.0

—

Heart failure and coronary heart disease

323

1.93

7.46

1.5

2.0

—

Endocrine, nutritional and metabolic diseases

128

368

1.76

7.42

3.0

2.2

—

Secondary thrombocytopenia

13.64

7.42

4.0

1.7

—

Hypoplasia of dental enamel

13.70

7.41

2.2

2.7

—

Collagenous colitis

3.54

7.41

2.2

1.7

—

Other/unspecified rheumatoid arthritis

3.26

7.37

2.8

1.7

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

202

2.38

7.31

1.8

2.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

170

2.27

7.30

1.7

2.2

—

Other diseases of the digestive system

285

2.14

7.26

2.2

2.1

—

Disorders of mineral metabolism

3.49

7.26

2.9

1.9

—

Abdominal and pelvic pain

161

494

1.64

7.25

2.4

2.2

—

Malignant neoplasm of skin

214

2.12

7.18

1.9

1.4

—

Cardiomyopathies, Primary/intrinsic

100

3.01

7.18

1.7

1.9

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

145

2.61

7.16

1.5

1.4

—

Osteonecrosis due to drugs

8.08

7.14

3.9

1.5

—

Molar incisor enamel hypoplasia, with caries

20.40

7.14

2.5

2.2

—

Abscess of anal and rectal regions

3.55

7.13

2.2

3.4

—

Presence of other functional implants

331

1.88

7.08

1.8

1.4

—

Chronic laryngitis and laryngotracheitis

3.03

7.02

2.0

2.3

—

Viral and other specified intestinal infections

131

2.69

7.00

1.7

2.4

—

Gastric ulcer

118

2.80

6.98

1.7

1.9

—

Urticaria and erythema

323

2.05

6.98

2.3

2.2

—

Unspecified kidney failure

3.15

6.97

2.1

1.4

—

Viral infections of the central nervous system, including avohilmo

3.86

6.97

2.9

1.6

—

Haemolytic anaemias

6.36

6.94

3.1

1.5

—

Disorders resulting from impaired renal tubular function

5.49

6.92

1.0

1.4

—

Malnutrition

7.61

6.92

2.3

1.7

—

Adjustment and management of implanted device

119

2.78

6.88

1.5

2.0

—

Convulsions, not elsewhere classified

123

2.73

6.86

1.4

2.2

—

Malignant neoplasm of brain, including Hilmo

6.71

6.81

1.6

1.0

—

Other/unspecified seropositive rheumatoid arthritis

209

2.30

6.80

1.8

2.0

—

Glomerular disorders in diseases classified elsewhere

2.97

6.79

1.6

2.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

102

580

1.76

6.79

1.7

2.1

—

Malignant neoplasm of digestive organs, including Hilmo

196

2.18

6.78

2.2

1.3

—

Cardiomyopathy (excluding other)

104

2.89

6.72

1.7

1.9

—

Rheumatoid arthritis, including avohilmo

335

2.00

6.70

2.2

2.1

—

Viral infections of the central nervous system

3.90

6.70

3.0

1.6

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

196

2.32

6.65

2.4

—

Other cataract

322

1.89

6.63

2.4

2.1

—

Marginal zone B-cell lymphoma, including Hilmo

12.42

6.60

3.1

1.0

—

Eosinophilia

8.83

6.58

1.5

—

Hypokalaemia

100

2.91

6.57

1.8

2.1

—

DVT of lower extremities

164

2.45

6.49

2.5

2.0

—

Procreative management

254

2.05

6.46

2.4

2.3

—

Seropositive rheumatoid arthritis, wide

214

2.25

6.46

1.8

2.0

—

Diaphragmatic hernia

347

1.96

6.44

2.0

1.9

—

Other and unspecified drugs and medicaments

3.51

6.43

1.3

1.9

—

Acute bronchiolitis

3.70

6.41

2.8

2.6

—

Crohn disease

107

2.81

6.40

2.0

2.4

—

Malignant neoplasm of bronchus and lung

2.82

6.40

1.4

1.3

—

Basal cell carcinoma, including Hilmo

202

2.08

6.38

1.5

1.4

—

Crohn's disease NAS

3.74

6.36

1.8

2.1

—

Respiratory tuberculosis, confirmed, including avohilmo

8.24

6.35

1.5

—

Misadventures to patients during surgical and medical care

102

2.85

6.35

1.8

1.4

—

Other diseases of pericardium

5.97

6.30

1.4

1.6

—

Hodgkin lymphoma, hilmo

6.32

6.17

4.3

1.5

—

Keratitis

332

1.96

6.16

2.2

2.3

—

Viral warts

3.21

6.13

2.1

2.3

—

Non-small cell lung cancer

3.79

6.13

1.3

—

Diplopia

110

2.74

6.10

1.6

2.1

—

Personal history of malignant neoplasm

4.12

6.08

2.1

1.3

—

Squamous cell neoplasms and carcinomas of the skin

4.11

6.07

1.9

1.4

—

Unspecified privation

3.02

6.06

1.3

2.1

—

Malignant neoplasm of mesothelium and soft tissue

8.62

6.06

1.3

1.0

—

Idiopathic thrombocytopenic purpura

6.73

6.04

2.1

1.4

—

Other abnormal findings of blood chemistry

5.19

6.01

2.0

1.6

—

Other specified/unspecified systemic involvement of connective tissue

5.55

5.99

1.7

2.2

—

Atrial fibrillation and flutter with reimbursement

118

2.35

5.96

1.9

2.1

—

Diseases of the eye and adnexa

119

356

1.68

5.94

2.5

—

Open wound of lower leg

129

2.56

5.93

1.5

2.4

—

Otitis media, unspecified

3.08

5.89

2.3

2.5

—

Exposure to unspecified factor

166

744

1.52

5.88

1.8

2.2

—

Other diseases of urinary system

161

587

1.54

5.88

2.1

2.2

—

Myocarditis

6.39

5.85

1.9

2.5

—

Methotrexate

3.40

5.85

1.9

2.6

—

Anaemia in chronic diseases classified elsewhere

5.84

5.85

1.5

1.4

—

Special screening examination for other diseases and disorders

3.29

5.84

1.5

2.1

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

8.05

5.84

1.2

1.0

—

Hard cardiovascular diseases

140

523

1.58

5.81

1.8

2.3

—

Acute suppurative otitis media

178

2.25

5.79

2.0

2.6

—

Pruritus

3.01

5.79

1.8

1.9

—

Benzodiazepine use

161

714

1.52

5.79

2.0

2.2

—

Otalgia

3.47

5.72

1.5

1.9

—

R07AX Other respiratory system products

+∞

5.69

1.2

0.0

—

Malignant neoplasm of stomach

6.11

5.68

2.7

1.3

—

Suppurative and unspecified otitis media

246

2.02

5.67

2.0

2.4

—

Respiratory tuberculosis, confirmed

7.60

5.65

1.5

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

7.60

5.65

1.5

—

Polycystic ovarian syndrome, consortium definition

313

1.74

5.64

1.9

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

117

2.36

5.61

1.8

2.3

—

Malignant immunoproliferative diseases

8.68

5.59

3.5

1.5

—

Chronic ulcer of skin, not elsewhere classified

3.41

5.58

1.6

1.5

—

Drug-induced osteoporosis with pathological fracture

8.59

5.57

1.1

1.5

—

Other arthritis (FG)

255

2.04

5.56

2.1

2.4

—

Malignant neoplasm of stomach, including Hilmo

5.86

5.52

2.7

1.4

—

Hypoplasia of dental enamel , including avohilmo

5.89

5.50

2.4

2.2

—

Symptoms and signs involving speech and voice

304

1.94

5.50

1.4

2.2

—

Acute pharyngitis

2.85

5.50

1.8

2.8

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

201

1.99

5.49

1.7

1.4

—

Viral and other specified intestinal infections, including avohilmo

183

2.21

5.46

1.7

2.3

—

Disorders of calcium metabolism

3.48

5.45

1.8

1.5

—

Lung diseases due to external agents

117

2.57

5.44

1.2

1.6

—

Cardiomyopathy, other and unspecified

3.35

5.44

1.7

2.0

—

Mantle cell lymphoma

16.32

5.43

3.8

1.0

—

ILD medications: pirfenidone

16.29

5.43

1.6

1.0

—

Symptoms and signs involving the urinary system

128

615

1.57

5.42

2.1

—

Substance use, excluding alcohol

166

2.29

5.42

1.5

2.6

—

External causes of morbidity and mortality

267

1.75

5.41

2.4

1.8

—

Urticaria

251

2.03

5.41

2.2

2.3

—

Chorioretinal inflammation

6.25

5.39

1.3

1.5

—

Retinal haemorrhage

5.66

5.38

2.1

1.4

—

Antihypertensive medication - note that there are other indications

272

1.75

5.38

2.7

2.4

—

Other disorders of kidney and ureter

112

2.60

5.37

1.8

2.1

—

Other (seronegative) rheumatoid arthritis, wide

148

2.37

5.37

2.7

2.0

—

Pneumonia due to Streptococcus pneumoniae

7.90

5.34

3.1

1.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

155

649

1.51

5.34

2.4

2.1

—

Viral warts, including avohilmo

180

2.23

5.33

1.8

2.6

—

Drug-induced polyneuropathy

11.53

5.32

4.6

1.6

—

Molar incisor enamel hypoplasia

5.61

5.31

2.4

2.3

—

Pulmonary eosinophilia, not elsewhere classified

9.27

5.31

2.1

1.4

—

Hypothyroidism, drug reimbursement

5.08

5.28

1.8

1.1

—

Malignant neoplasm of brain

6.71

5.25

1.8

1.0

—

Percutaneous Coronary Intervention

133

520

1.56

5.22

1.8

2.3

—

Disorders of sclera, cornea, iris and ciliary body

552

1.67

5.21

2.2

—

Sequelae of other external causes

3.65

5.20

3.7

1.8

—

Coronary revascularization (ANGIO or CABG)

133

520

1.55

5.19

1.8

2.3

—

Ulcer of lower limb, not elsewhere classified

126

2.47

5.19

1.5

1.9

—

Malignant neoplasm of breast, HER2-negative

121

2.24

5.18

2.7

1.3

—

Disorders of continuity of bone

2.88

5.18

2.3

—

Abnormalities of heart beat

221

2.06

5.17

1.9

2.3

—

Hernia

149

657

1.51

5.16

2.2

2.1

—

Disorders of gallbladder, biliary tract and pancreas

157

654

1.49

5.15

2.2

2.1

—

Gout, strict definition

170

2.24

5.15

1.5

1.7

—

Ulcerative colitis, NAS

115

2.53

5.11

1.9

2.3

—

Hypertension, Pulmonary Arterial

13.62

5.10

1.4

1.2

—

Malignant neoplasm of breast

122

2.22

5.09

2.7

1.3

—

Fall on same level

180

658

1.46

5.09

1.8

2.3

—

Intracranial and intraspinal abscess and granuloma

8.49

5.08

1.2

1.5

—

Fitting and adjustment of other devices

249

1.95

5.08

1.6

2.1

—

Dilated cardiomyopathy

116

2.51

5.03

1.7

2.0

—

Cardiodefibrillation

356

1.82

5.02

1.6

2.0

—

5-aminosalicylic acid

2.63

4.97

1.7

3.0

—

Other congenital malformations, including avohilmo

2.63

4.96

2.9

2.1

—

Malignant neoplasm of digestive organs

190

2.01

4.94

1.9

1.3

—

Exclusions for E4_PCOS_BROAD

154

2.28

4.93

1.9

2.2

—

Acquired haemolytic anaemia

5.48

4.92

3.7

1.5

—

Unspecified chronic bronchitis

6.04

4.91

2.3

1.5

—

Ischemic heart diseases

136

531

1.53

4.89

1.7

2.3

—

Nonischemic cardiomyopathy

2.67

4.89

1.4

1.9

—

Other diseases of oesophagus

3.22

4.88

1.6

1.7

—

Respiratory tuberculosis, not confirmed, including avohilmo

4.58

4.86

1.1

1.4

—

Seropositive rheumatoid arthritis, strict definition

112

2.51

4.86

1.9

2.0

—

Emergency coronary revascularization (for ACS)

140

560

1.51

4.83

1.8

2.2

—

Explicit fungal Sepsis

9.27

4.82

1.7

—

Explicit fungal Sepsis, including avohilmo

9.26

4.82

1.7

—

Benign neoplasm of colon, rectum, anus and anal canal

108

579

1.58

4.81

1.8

2.1

—

Postmenopausal osteoporosis with pathological fracture

4.85

4.80

1.2

1.3

—

Other diseases of liver

156

2.25

4.80

1.4

2.2

—

Malignant neoplasm of other connective and soft tissue

9.07

4.79

1.3

1.0

—

Non-rheumatic valve diseases

312

1.74

4.77

1.7

2.2

—

Need for other prophylactic measures

3.42

4.74

1.5

2.1

—

Missing teeth due to accident, extraction or parodontitis

104

587

1.58

4.74

2.4

2.0

—

Irregular menses

253

1.84

4.74

2.0

2.1

—

Any operation in hilmo

+∞

4.72

1.5

0.0

—

Nonsuppurative otitis media, including avohilmo

221

1.96

4.70

2.1

2.5

—

Cerebrovascular diseases (FINNGEN)

153

2.06

4.67

2.2

2.4

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

126

2.14

4.67

2.7

1.3

—

Malignant neoplasm of breast, including Hilmo

126

2.14

4.66

2.7

1.3

—

Hypercalcemia

4.31

4.63

1.7

1.5

—

Other or unspecified immunodeficiency

14.60

4.62

2.7

1.2

—

Cutaneous abscess, furuncle and carbuncle

232

1.99

4.62

3.0

2.4

—

Allergic urticaria

3.22

4.61

1.9

—

Cholangitis (primary sclerosing, PSC)

3.35

4.60

1.2

1.6

—

Fibrosis and cirrhosis of liver

2.91

4.60

1.3

1.8

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

14.30

4.60

4.0

1.0

—

Abnormality of white blood cells, not elsewhere classified

8.37

4.59

3.2

1.6

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

8.31

4.58

1.6

1.5

—

Asthma mixed form (mode)

14.03

4.57

1.3

1.6

—

Asthma mixed form (mode), excluding more controls

14.03

4.57

1.3

1.6

—

Carcinoma in situ of skin of other and unspecified parts of face

2.98

4.55

2.4

1.3

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

10.09

4.53

1.1

1.0

—

Intestinal malabsorption

4.19

4.51

1.5

1.6

—

Other functional intestinal disorders

402

1.70

4.51

1.7

2.1

—

Other and unspecified local infections of skin and subcutaneous tissue

2.72

4.50

1.2

2.2

—

Small fibre neuropathy

4.86

4.50

3.1

1.5

—

Valvular heart disease excluding rheumatic fever

318

1.71

4.50

1.7

2.2

—

Drug-induced adrenocortical insufficiency

6.74

4.48

1.6

1.5

—

Haemorrhage, not elsewhere classified

6.70

4.47

1.8

1.7

—

Malignant neoplasm of head and neck, including Hilmo

3.27

4.46

1.8

1.4

—

Dental operations

260

1.68

4.45

2.2

1.7

—

Other or unspecified ileus, impaction or obstruction

155

2.20

4.44

2.2

2.1

—

Other diseases of anus and rectum

284

1.86

4.42

2.5

2.2

—

Basal cell carcinoma

195

1.89

4.40

1.4

—

Other symptoms and signs involving the circulatory and respiratory systems

4.07

4.40

1.5

2.2

—

Cytomegaloviral pneumonitis

12.83

4.38

2.0

1.5

—

Monocytic leukaemia

12.25

4.33

3.0

1.2

—

Other dialysis

4.28

4.33

1.0

1.5

—

Respiratory tuberculosis, not confirmed

4.27

4.32

1.1

1.4

—

Malignant neoplasm of eye, brain and central nervous system

5.03

4.32

1.8

1.0

—

Major coronary heart disease event

136

550

1.48

4.30

1.7

2.2

—

Anxiety disorders, excluding more controls

130

558

1.49

4.29

2.0

2.2

—

Primary biliary cholangitis (PBC)

8.96

4.28

1.0

1.4

—

Acute nasopharyngitis (common cold)

2.71

4.27

3.0

2.7

—

Adrenocortical insufficiency

4.51

4.25

1.6

1.9

—

Diseases of the ear and mastoid process

170

599

1.42

4.24

2.0

2.2

—

Other disorders of adrenal gland

4.14

4.21

1.6

1.8

—

Polyuria

199

2.01

4.20

2.6

2.0

—

Reactive arthropathies, FINNGEN

3.15

4.20

1.9

2.2

—

Endocarditis

4.83

4.18

1.3

1.8

—

Mental and behavioural disorders due to tobacco

2.75

4.18

1.8

2.2

—

Rash and other nonspecific skin eruption

2.75

4.18

1.8

—

Benign neoplasm: Colon

549

1.57

4.17

1.9

2.0

—

Hypersensitivity pneumonitis due to organic dust

5.31

4.16

1.3

1.5

—

Functional dyspepsia

214

1.97

4.14

2.2

2.1

—

Subjective visual disturbances

228

1.93

4.13

2.4

2.1

—

Malignant neoplasm, without specification of site, including Hilmo

5.90

4.12

2.5

1.0

—

Unknown and unspecified causes of morbidity

4.35

4.12

1.7

1.9

—

Other disorders of urethra and urinary system

106

481

1.53

4.10

2.1

2.0

—

Protein-energy malnutrition of moderate and mild degree

8.15

4.08

1.9

1.7

—

Other bacterial agents as the cause of diseases classified to other chapters

8.14

4.08

1.6

1.5

—

Secondary hypertension

3.22

4.07

1.1

2.5

—

Disorders of thyroid, IBD co-morbidities

2.77

4.07

1.3

2.2

—

Weight loss

2.63

4.06

1.3

1.7

—

Other congenital malformations

2.86

4.05

3.4

1.9

—

Phlebitis and thrombophlebitis (not including DVT)

202

1.98

4.05

2.0

—

Low back pain

118

533

1.49

4.04

1.7

2.3

—

Voice disturbances

244

1.89

4.04

1.3

2.0

—

Deviated nasal septum

280

1.82

4.01

1.8

2.5

—

Sequelae of tuberculosis

6.49

3.99

1.2

1.4

—

Sequelae of tuberculosis, including avohilmo

6.49

3.99

1.2

1.4

—

Primary Sclerosing Cholangitis, IBD and UDCA required

6.48

3.99

1.1

1.9

—

Smoking dependency

2.68

3.98

1.9

2.2

—

Other diseases of intestine

143

2.17

3.97

1.7

2.3

—

Other general symptoms and signs

5.52

3.94

1.3

1.6

—

Other diseases of hard tissues of teeth

244

1.66

3.91

1.6

1.8

—

Disorders of optic nerve and visual pathways

2.72

3.91

1.8

—

Vitamin B12 deficiency anaemia

2.72

3.91

1.8

1.4

—

Genitourinary diseases

267

1.62

3.90

2.5

2.2

—

Other or ill-defined heart diseases

3.80

3.89

1.3

2.3

—

Diseases of tongue

3.80

3.89

1.8

2.5

—

Amenorrhoea

4.79

3.86

2.5

2.0

—

Inflammatory bowel disease

299

1.78

3.85

1.9

2.5

—

Neurological diseases

125

425

1.48

3.84

2.2

2.3

—

Other disorders of bone

152

2.11

3.82

2.2

2.4

—

Insulin, combination of fast acting with intermediate-acting or long-acting

586

1.52

3.80

2.4

2.2

—

Malignant neoplasm of breast, HER-positive

111

2.15

3.79

2.0

1.3

—

Other local infections of skin and subcutaneous tissue

2.48

3.79

1.2

2.2

—

Malignant neoplasm of breast, ER-positive, including Hilmo

111

2.15

3.78

2.0

1.3

—

Seronegative rheumatoid arthritis

2.57

3.71

3.6

2.1

—

Viral meningitis, including avohilmo

5.02

3.69

3.3

1.8

—

Insulin, fast-acting

348

1.70

3.68

2.6

2.3

—

Essential (haemorrhagic) thrombocythaemia

6.69

3.67

2.0

1.0

—

Disorders of conjunctiva

126

679

1.44

3.67

2.1

2.2

—

SLE (Finngen)

5.65

3.66

1.2

3.0

—

Atopic dermatitis, strict definition with reimbursement

215

1.88

3.64

2.0

2.3

—

Malignant neoplasm of kidney, except renal pelvis

3.12

3.64

3.3

1.3

—

Malignant neoplasm of urinary organs, including Hilmo

2.86

3.62

3.1

1.2

—

Diseases of the musculoskeletal system and connective tissue

222

1.65

3.61

2.0

2.4

—

Disorders of parathyroid gland

161

2.03

3.58

1.7

1.9

—

Other inflammatory liver diseases

2.95

3.57

2.3

1.6

—

Polymyalgia rheumatica

2.40

3.55

1.6

1.7

—

Complications following infusion, transfusion and therapeutic injection

5.36

3.52

4.2

1.5

—

Pyogenic arthritis

2.82

3.52

1.9

2.8

—

Unspecified nephritic syndrome

5.34

3.51

1.2

1.5

—

Infection of intervertebral disc (pyogenic)

6.23

3.51

1.4

1.8

—

Marginal zone B-cell lymphoma

10.14

3.51

4.0

1.0

—

Postprocedural disorders of digestive system, not elsewhere classified

4.26

3.51

1.5

1.4

—

Primary biliary cholangitis, wide definition

6.20

3.50

1.0

1.6

—

Epilepsy

285

1.75

3.50

2.3

2.4

—

Idiopathic gout

2.33

3.49

1.5

1.9

—

Pain (limb, back, neck, head abdominally)

324

1.52

3.44

2.2

2.3

—

Neurotic, stress-related and somatoform disorders

133

650

1.41

3.44

2.0

2.2

—

Congenital malformations of the respiratory system, including avohilmo

4.59

3.43

1.6

1.9

—

Paralytic ileus and intestinal obstruction

229

1.83

3.43

2.2

2.1

—

Pericarditis

4.57

3.43

2.3

1.5

—

Anxiety disorders

134

654

1.41

3.41

2.0

2.2

—

Malignant neoplasm of urinary organs

2.99

3.41

3.3

1.3

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

2.98

3.41

3.3

1.3

—

Type 2 diabetes, wide definition

126

558

1.42

3.40

2.0

2.1

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

113

2.22

3.40

2.2

1.3

—

Hypothyroidism, strict autoimmune

420

1.50

3.40

1.8

2.2

—

Chronic tubulo-interstitial nephritis

4.09

3.39

2.0

1.3

—

Fracture of lumbar spine and pelvis

187

1.92

3.39

1.5

1.9

—

Disorders of plasma-protein metabolism, not elsewhere classified

7.15

3.38

2.0

1.5

—

Nonalcoholic fatty liver disease

2.45

3.38

1.2

2.2

—

Impacted teeth

119

2.09

3.35

3.0

2.6

—

Respiratory tuberculosis, clinically confirmed

5.79

3.35

1.0

1.4

—

Use of memantine

196

0.33

3.34

1.3

1.4

—

Use of other anti-dementia drugs

196

0.33

3.34

1.3

1.4

—

Vasomotor and allergic rhinitis

276

1.74

3.34

1.8

2.6

—

Spondylopathies

118

485

1.44

3.34

1.8

2.2

—

Other diseases of lip and oral mucosa

405

1.61

3.33

2.3

2.2

—

Colectomy operation

148

2.03

3.29

1.7

2.1

—

8.81

3.28

1.3

1.1

—

ILD and respiratory illness in diseases classified elsewhere

8.79

3.28

1.3

1.1

—

Other embolism and thrombosis

102

2.26

3.28

2.3

1.9

—

Insulin, fast-acting or short human

360

1.64

3.28

2.6

2.3

—

Presence of other devices

180

1.92

3.26

1.7

1.4

—

Other endocrine disorders

2.93

3.26

3.0

1.9

—

Other/unspecified reactive arthropathies

2.79

3.25

1.9

2.1

—

Malignant neoplasm of head and neck

3.03

3.24

1.9

1.4

—

Congenital malformations of the respiratory system

4.78

3.24

1.7

2.1

—

Diseases of oral cavity, salivary glands and jaws

244

1.58

3.23

1.6

1.8

—

Irritable bowel syndrome

227

1.81

3.22

2.0

2.3

—

Speech and linguistic disorders, excluding more controls

2.69

3.21

1.9

2.7

—

Seborrhoeic dermatitis

2.51

3.20

1.2

2.0

—

Speech and linguistic disorders

2.59

3.20

1.9

2.8

—

Excessive, frequent and irregular menstruation

132

1.82

3.20

2.2

1.8

—

Spondylopathies in diseases classified elsewhere

6.44

3.19

1.3

1.7

—

Dermatopolymyositis (FG)

6.43

3.19

1.7

1.3

—

Fracture of rib(s), sternum and thoracic spine

287

1.71

3.19

1.8

2.1

—

Insulin medication

557

1.46

3.19

2.4

2.2

—

Other disorders of eye and adnexa

110

2.19

3.18

1.8

2.3

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

171

1.93

3.17

1.3

1.5

—

Injury, poisoning and certain other consequences of external causes

219

1.60

3.15

2.2

1.8

—

Diseases of salivary glands

296

1.69

3.14

1.9

2.1

—

Lichen simplex chronicus and prurigo

2.96

3.13

2.2

1.6

—

Infectious mononucleosis

2.96

3.13

3.2

3.3

—

Infectious mononucleosis, including avohilmo

2.96

3.13

3.2

3.3

—

Benign neoplasm: salivary glands, exclude unknown (D119)

2.47

3.12

1.1

1.9

—

Other shoulder lesions

2.47

3.12

1.4

2.6

—

Viral meningitis

4.52

3.11

3.6

1.7

—

Herpesviral keratitis and keratoconjunctivitis

3.44

3.10

1.8

1.5

—

Chronic pancreatitis

118

2.12

3.09

1.3

2.2

—

Acquired absence of limb

7.59

3.06

1.0

1.8

—

Hypo-osmolality and hyponatraemia

158

1.95

3.06

1.8

1.9

—

Eustachian salpingitis and obstruction

2.69

3.05

1.7

2.8

—

Certain conditions originating in the perinatal period

2.72

3.05

3.5

2.4

—

Malignant melanoma

2.38

3.05

2.8

1.3

—

Reactive arthropathies

2.44

3.04

1.8

2.3

—

Dermatopolymyositis

5.89

3.03

1.7

1.3

—

Disorders in reading

5.88

3.02

2.0

—

Other/unspecified dorsalgia

349

1.61

3.00

2.4

2.3

—

Soft tissue disorders

145

544

1.37

3.00

1.9

2.3

—

Viral agents as the cause of diseases classified to other chapters

4.32

3.00

2.3

1.5

—

Viral agents as the cause of diseases classified to other chapters, including avohilmo

4.31

3.00

2.3

1.5

—

Systemic lupus erythematosus

4.31

2.99

1.2

2.1

—

Hyperlipidaemia, other/unspecified

366

1.57

2.99

1.5

2.0

—

Disorders of choroid and retina

124

626

1.39

2.99

1.7

2.2

—

Other and unspecified tonsillitis

198

1.76

2.98

2.4

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

585

1.45

2.97

2.2

2.3

—

Abnormal weight loss

2.41

2.96

1.2

1.6

—

Disorders of skin appendages

471

1.52

2.96

1.7

2.4

—

Benign neoplasms

139

553

1.37

2.95

2.5

2.2

—

Elevated blood glucose level

2.55

2.95

1.1

2.0

—

Alzheimer disease, including avohilmo

255

0.43

2.93

1.5

1.6

—

Diseases of spleen

4.75

2.92

3.6

1.4

—

Delivery

188

0.42

2.92

2.1

1.8

—

Systemic lupus erythematosus, unspecified

4.73

2.92

1.3

2.4

—

Malignant neoplasm of ovary, including Hilmo

4.72

2.92

1.1

1.0

—

Injuries to the thorax

483

1.51

2.91

2.2

—

Delivery, wide proxy

166

0.38

2.91

2.5

1.8

—

Other specified and unspecified retinal disorders

3.46

2.90

2.5

1.6

—

Lower back pain or/and sciatica

156

727

1.33

2.89

1.7

2.2

—

Diabetic nephropathy, excluding more controls

2.13

2.89

1.3

2.4

—

Volume depletion

2.37

2.89

1.7

1.6

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

5.47

2.88

3.9

1.4

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

4.10

2.88

1.9

1.5

—

Complications of other internal prosthetic devices, implants and grafts

3.72

2.88

1.8

1.3

—

Adult respiratory distress syndrome

5.44

2.88

2.6

1.4

—

Other specified/unspecified necrotizing vasculopathies

5.44

2.87

1.4

1.5

—

Malignant neoplasm of small intestine, including Hilmo

5.41

2.87

3.0

1.0

—

Other specified/unspecified arthritis

244

1.72

2.85

2.1

2.4

—

Somatoform disorder

136

1.99

2.84

2.1

2.2

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

164

1.89

2.84

2.6

2.3

—

Optic atrophy, wide definition

4.48

2.80

2.4

1.7

—

Malignant neoplasm of bladder, including Hilmo

2.56

2.79

1.1

1.3

—

Malignant melanoma, including Hilmo

2.23

2.79

2.8

1.4

—

Hypertension, essential

111

447

1.40

2.79

2.0

2.4

—

Disorders of tooth development and eruption

2.13

2.78

2.2

2.6

—

Oesophageal obstruction

3.93

2.77

1.1

1.8

—

Clear cell adenocarcinoma of kidney

3.93

2.77

1.4

1.3

—

Malignant neoplasm of colon, including Hilmo

103

2.13

2.77

1.2

1.3

—

Hypersplenism

8.55

2.77

4.8

1.0

—

Thrombotic microangiopathy

8.48

2.76

2.0

1.2

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

5.08

2.74

2.7

1.4

—

Problems related to lifestyle

2.37

2.72

2.0

2.8

—

Hyperparathyroidism

137

1.95

2.71

1.8

1.7

—

Disease of hard tissues of teeth, NOS

239

1.53

2.70

1.8

—

Coxarthrosis [arthrosis of hip](FG)

357

1.48

2.70

1.7

2.3

—

Other epidermal thickening

3.46

2.69

2.0

1.2

—

Non-small cell lung cancer, adenocarcinoma

3.46

2.69

1.3

1.4

—

Female infertility, associated with anovulation

4.22

2.67

1.6

2.3

—

Use of donepezil

163

0.29

2.67

2.0

1.4

—

370

1.53

2.67

1.8

1.7

—

Ulcerative colitis

219

1.74

2.67

1.7

2.3

—

Single spontaneous delivery

188

0.45

2.66

2.1

1.8

—

Hypertensive diseases

114

465

1.38

2.65

2.0

2.4

—

Hypertension

114

465

1.38

2.64

2.0

2.4

—

Malignant neoplasm of endocrine gland, including Hilmo

3.15

2.64

3.3

1.2

—

Other superficial mycoses, including avohilmo

2.39

2.63

1.5

2.2

—

Alzheimer disease

221

0.42

2.62

1.6

1.5

—

Varicella [chickenpox]

2.94

2.62

2.2

—

Varicella [chickenpox], including avohilmo

2.66

2.62

2.3

2.1

—

Polypectomy (DHB20)

2.47

2.62

1.0

1.9

—

Acute posthaemorrhagic anaemia

3.35

2.60

1.7

1.4

—

Diseases of peritoneum

2.26

2.60

1.2

1.8

—

Focal epilepsy, strict definition

177

1.81

2.58

2.6

2.3

—

Congenital malformations, deformations and chromosomal abnormalities

533

1.44

2.58

2.3

—

Exposure to other specified factors

119

756

1.35

2.57

2.0

2.2

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

3.62

2.57

3.1

1.3

—

Third [oculomotor] nerve palsy

4.03

2.57

1.4

—

Paraplegia, diplegia of upper limbs

4.03

2.57

3.3

1.5

—

Malignant neoplasm of breast, ER-negative, including Hilmo

2.15

2.57

3.0

1.3

—

SLE, ICD10

4.02

2.57

1.3

2.2

—

SLE, strict definition

4.02

2.57

1.3

2.2

—

Selective deficiency of immunoglobulin G [IgG] subclasses

7.26

2.56

2.6

1.7

—

Pyoderma gangrenosum

7.24

2.56

1.2

1.3

—

Intestinal stricture

299

1.61

2.54

2.0

—

Entropion and trichiasis of eyelid

2.42

2.53

3.9

1.5

—

Benign neoplasm of major salivary glands

2.23

2.53

1.1

1.9

—

Adverse effects, not elsewhere classified

171

1.82

2.53

1.6

2.4

—

Other Crohn's disease

2.61

2.53

2.2

—

Acute peritonitis

2.51

2.53

1.2

1.6

—

Conjunctivitis

107

628

1.37

2.53

2.3

2.2

—

Demyelinating diseases of the central nervous system

2.61

2.53

1.2

2.2

—

Personal history of other diseases and conditions

2.72

2.52

1.9

1.4

—

Malignant neoplasm of breast, HER-negative

2.17

2.52

3.1

1.3

—

Other specific joint derangements/joint disorders

102

457

1.39

2.51

2.2

2.4

—

Other arrhythmias

432

1.43

2.51

2.1

2.2

—

Diabetes, varying definitions

147

648

1.32

2.50

2.4

2.1

—

Unspecific neurodegenerative disorder

309

0.53

2.50

1.3

1.6

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

143

1.89

2.50

2.1

—

Acute lymphadenitis

2.98

2.48

1.6

2.1

—

Presence of cardiac and vascular implants and grafts

259

1.56

2.48

1.9

1.4

—

Other autoimmune haemolytic anaemias

4.42

2.48

5.3

1.4

—

Atypical facial pain

3.47

2.48

1.4

2.4

—

Other and unspecified urticaria

165

1.82

2.48

2.1

2.4

—

Other disorders of ear

134

653

1.33

2.47

1.9

2.2

—

Alzheimer’s disease, strict definition

181

0.40

2.45

1.8

1.4

—

Other retinal disorders

531

1.39

2.45

1.8

2.1

—

Follow-up examination after treatment for malignant neoplasms

2.55

2.44

3.5

1.6

—

Dorsalgia

136

543

1.33

2.44

1.8

2.3

—

Skin changes due to chronic exposure to nonionizing radiation

352

1.52

2.43

1.6

1.7

—

Hydronephrosis

2.09

2.42

1.9

2.0

—

Paracetamol or NSAID medication

1.99

2.41

1.7

2.9

—

Depression

137

697

1.31

2.39

2.3

2.2

—

AV-block

117

1.90

2.39

2.5

1.8

—

Benign neoplasm: Parotid gland

2.35

2.38

1.1

1.7

—

Colitis, primary sclerosing

6.29

2.37

1.0

1.8

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

6.28

2.37

1.2

1.0

—

malignant neoplasm of female genital organs, including Hilmo

2.22

2.37

1.1

1.2

—

Dependence on enabling machines and devices, not elsewhere classified

6.28

2.37

2.0

1.9

—

Shoulder lesions

107

470

1.36

2.36

2.1

2.2

—

Tongue abnormality

2.62

2.36

1.9

1.5

—

Hepatic failure, not elsewhere classified

3.04

2.36

1.2

1.6

—

Acute gastritis

2.83

2.34

1.3

2.3

—

Malignant melanoma of skin, including Hilmo

2.26

2.34

2.5

1.2

—

Other dorsopathies, not elsewhere classified

138

545

1.32

2.33

1.9

2.3

—

Fissure and fistula of anal and rectal regions

221

1.68

2.33

2.2

2.4

—

Fracture of shoulder and upper arm

354

1.52

2.32

1.7

2.3

—

Other salmonella infections

3.23

2.31

2.7

1.3

—

Embedded and impacted teeth

166

1.71

2.31

3.4

2.4

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

3.22

2.30

1.9

1.4

—

Actinic keratosis

344

1.51

2.30

1.6

1.7

—

Any mental disorder

155

601

1.29

2.29

2.2

2.1

—

Other congenital malformations of skin, including avohilmo

2.38

2.29

3.6

1.7

—

Ocular pain

2.38

2.29

1.9

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

137

702

1.30

2.28

1.8

2.2

—

Osteopathy in diseases classified elsewhere

4.69

2.28

1.5

—

Toxic liver disease

4.65

2.27

4.7

1.6

—

Colorectal cancer, including Hilmo

151

1.79

2.27

1.4

—

Nystagmus and other irregular eye movements

4.65

2.27

1.3

1.8

—

Malignant neoplasm, without specification of site

4.63

2.27

3.0

1.0

—

Neuralgia and neuritis, unspecified

2.76

2.27

1.0

2.3

—

Ulcer of oesophagus

2.56

2.27

1.1

1.7

—

Pregnancy, childbirth and the puerperium

138

0.42

2.27

1.1

1.7

—

Degenerative diseases of the nervous system

257

0.50

2.26

1.4

1.5

—

Optic atrophy

3.92

2.25

2.6

1.7

—

Non-small cell lung cancer, squamous

3.90

2.25

1.1

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

3.90

2.25

2.0

—

Diabetes mellitus

146

652

1.29

2.24

2.2

—

Diverticular disease of intestine

101

462

1.36

2.23

1.7

2.1

—

Erosion of teeth , including avohilmo

224

1.65

2.23

2.9

2.4

—

Sleep apnoea

135

653

1.30

2.23

1.7

2.3

—

Congenital malformations of trachea and bronchus

5.62

2.22

1.0

1.3

—

Other specified and unspecified disorders of conjunctiva

5.61

2.22

1.2

1.3

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

476

1.43

2.22

1.7

2.2

—

Faecal incontinence

2.34

2.21

1.3

1.9

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

5.57

2.21

1.0

2.7

—

Acute laryngitis and tracheitis

2.34

2.21

3.6

2.4

—

Other and unspecified follicular disorders

2.87

2.21

2.1

1.5

—

Mucosal proctocolitis

107

1.97

2.20

1.2

2.4

—

Alzheimer’s disease (Late onset)

163

0.40

2.19

1.9

1.3

—

Unspecified misadventure during surgical and medical care

2.51

2.18

1.8

1.9

—

Short stature, not elsewhere classified

3.39

2.18

2.8

2.4

—

Use of anticholinesterases

261

0.50

2.18

1.4

1.6

—

N06DA Anticholinesterases

261

0.50

2.18

1.4

1.6

—

Other noninfective disorders of lymphatic vessels and lymph nodes

3.35

2.18

2.5

1.4

—

Optic neuritis

3.34

2.18

2.0

2.2

—

Myalgia

195

1.69

2.18

1.2

2.2

—

Acne vulgaris

2.50

2.17

1.0

2.6

—

Monoplegia

4.32

2.15

1.3

1.6

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

3.71

2.15

1.6

1.5

—

Dementia in Alzheimer disease

129

0.32

2.15

1.0

1.4

—

Status epilepticus

3.01

2.15

1.4

1.5

—

Malignant melanoma of skin

2.30

2.14

2.6

1.2

—

Focal epilepsy

196

1.68

2.14

2.5

2.3

—

Contusion of other and unspecified parts of foot

2.78

2.13

1.3

1.9

—

Ascites

2.37

2.12

2.1

1.9

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

465

1.43

2.12

1.7

2.4

—

Other symptoms and signs involving the digestive system and abdomen

130

1.85

2.11

3.4

2.1

—

Biological medication for rheuma

152

1.78

2.11

1.8

2.5

—

Other disorders of conjunctiva

123

1.87

2.11

1.1

2.0

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

2.21

2.10

3.8

2.4

—

Periodontitis

139

689

1.29

2.10

2.1

—

Specific development disorders of scholastic skills

2.95

2.09

2.2

3.3

—

Other diseases of spinal cord

2.92

2.07

2.8

1.4

—

Malignant neoplasm of small intestine

5.02

2.07

2.8

1.0

—

Male infertility

2.91

2.07

3.4

2.3

—

Other condition

117

1.88

2.05

2.5

2.1

—

Viral hepatitis, IBD co-morbidity

3.51

2.05

1.4

2.8

—

Cystitis

111

499

1.32

2.05

2.1

—

Paralytic strabismus

2.33

2.04

1.7

1.6

—

Crohn's disease of small intestine

2.33

2.04

2.8

2.1

—

Gout due to impairment of renal function

4.04

2.04

2.0

1.5

—

Migraine with aura

176

1.71

2.04

1.6

2.4

—

Malignant neoplasm of liver and intrahepatic bile ducts

4.01

2.04

1.5

1.0

—

Constipation

128

672

1.29

2.02

1.6

2.2

—

Other specified/unspecified bacterial intestinal infections

2.41

2.02

1.9

1.4

—

Disorders of refraction and accommodation

253

1.58

2.02

1.8

2.6

—

Corneal scars and opacities

3.09

2.01

2.1

1.5

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

3.09

2.01

5.1

1.7

—

Ovarian dysfunction

3.08

2.01

2.9

2.2

—

Visual field defects

2.23

2.00

2.4

1.9

—

Parkinson's disease, including avohilmo

145

0.34

2.00

1.2

1.8

—

Benign neoplasm of breast

2.23

2.00

1.0

1.9

—

Gingival hyperplasia

2.64

2.00

1.6

1.7

—

Total colectomy

2.82

2.00

1.7

1.4

—

Total colectomy operation

2.82

2.00

1.7

1.4

—

Autoimmune hepatitis, wide definition

2.82

2.00

2.8

2.1

—

Anogenital herpesviral [herpes simplex] infection

2.82

2.00

5.6

2.2

—

In situ neoplasms

368

1.47

1.99

2.5

1.7

—

Chronic periodontitis, including avohilmo

138

690

1.28

1.99

2.1

—

Unspecified haematuria

352

1.43

1.97

1.6

2.1

—

Carrier of infectious disease

3.35

1.96

1.0

1.5

—

Other demyelinating diseases of the central nervous system

3.34

1.96

1.1

2.2

—

Trochanteric bursitis

119

1.85

1.96

1.2

2.0

—

IBD patients in KELA-register

194

1.65

1.95

1.9

2.3

—

Chronic nephritic syndrome

2.57

1.94

1.6

1.5

—

Early complications of trauma

2.57

1.94

1.3

1.5

—

!Aliquae complicationes praecoces traumatis

2.57

1.94

1.3

1.5

—

Ischaemic heart disease, wide definition

114

538

1.30

1.94

1.7

2.2

—

Chronic hepatitis, not elsewhere classified

2.97

1.93

1.6

1.4

—

Hordeolum and other deep inflammation of eyelid

2.45

1.93

1.9

1.8

—

Malignant neoplasm of bladder

2.73

1.93

1.0

1.4

—

Distal bite

2.72

1.91

5.6

2.1

—

Tooth eruption problems

102

1.90

1.91

3.3

2.2

—

Type 2 diabetes

136

619

1.27

1.89

2.3

2.1

—

Other intervertebral disc disorders

110

502

1.31

1.89

1.8

2.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

106

1.81

1.89

1.7

2.0

—

Colonic or urogenital fistula

251

1.56

1.88

2.2

—

Keratoconus

3.20

1.88

1.0

1.5

—

Myositis

3.20

1.88

1.3

1.8

—

Other disorders of nervous system

2.16

1.88

1.6

—

Other disorders of eyelid

414

1.41

1.87

2.3

1.9

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

384

1.44

1.87

1.7

2.1

—

Benign neoplasm: Skin, unspecified

2.66

1.86

1.3

—

Other salmonella infections, including avohilmo

2.65

1.86

2.7

1.8

—

Cerebrovascular diseases

106

563

1.31

1.86

1.8

2.1

—

Other noninflammatory disorders of cervix uteri

2.86

1.86

1.6

2.2

—

Other maternal disorders predominantly related to pregnancy

288

0.61

1.86

1.5

2.1

—

Acne

2.14

1.85

1.0

3.0

—

Conduction disorders

207

1.55

1.84

2.6

2.1

—

Portal vein thrombosis

3.55

1.84

3.7

1.5

—

Erythema nodosum

3.54

1.84

2.3

1.2

—

Diabetic nephropathy

135

1.76

1.83

1.3

2.1

—

Exclusions for E4_PCOS_CONSORTIUM

399

1.35

1.83

1.8

2.2

—

Endocrine disorders, other/unspecified

4.19

1.82

3.8

1.4

—

Malignant neoplasm of tonsil and base of tongue

4.19

1.82

2.6

1.0

—

Persons with potential health hazards related to communicable diseases

307

1.49

1.81

1.9

2.4

—

Emotional disorders and disorders of social functioning with onset specific to childhood

2.60

1.81

5.0

3.1

—

Other gastritis (incl. Duodenitis)

160

1.69

1.81

1.9

2.0

—

Other and unspecified effects of external causes

230

1.57

1.80

2.0

2.5

—

Other diseases of stomach and duodenum

2.58

1.80

4.0

1.7

—

Conjunctivitis (acute, non atopic)

245

1.55

1.80

3.1

2.3

—

Non-allergic asthma

2.06

1.80

1.4

2.2

—

Superficial injury of thorax

123

1.79

2.1

2.2

—

Disorders of orbit

2.77

1.79

3.3

1.4

—

Diseases of male genital organs

304

1.36

1.79

2.5

—

Other and unspecified coagulation defects

2.76

1.79

2.8

2.1

—

Spinal stenosis

387

1.37

1.78

1.4

2.2

—

Benign neoplasm: Colon, unspecified

247

1.54

1.77

1.8

2.0

—

Dorsopathies

137

550

1.26

1.77

2.0

2.3

—

Pollen allergy

144

1.71

1.76

2.0

2.8

—

Other obstetric conditions, not elsewhere classified

114

0.44

1.76

1.9

2.2

—

Episodal and paroxysmal disorders

144

583

1.25

1.76

2.1

2.3

—

Benign neoplasm: Sigmoid colon

177

1.64

1.75

2.1

2.0

—

Other abnormalities of plasma proteins

3.36

1.75

1.5

1.4

—

Other and unspecified epidermal thickening

3.35

1.75

1.0

1.3

—

Gonarthrosis [arthrosis of knee](FG)

415

1.32

1.74

1.7

2.3

—

STROKE

383

1.35

1.74

2.1

2.3

—

Meningitis

2.51

1.74

1.8

1.7

—

Other disorders of optic [2nd] nerve and visual pathways

2.23

1.74

2.1

1.9

—

Carcinoma in situ of skin of trunk

2.68

1.72

1.8

1.4

—

Arterial embolism and thrombosis of lower extremity artery

2.67

1.72

2.3

1.5

—

Abnormal blood-pressure reading, without diagnosis

2.92

1.72

1.6

2.4

—

Pain in joint

318

1.37

1.72

2.1

2.3

—

Dyshidrosis [pompholyx]

3.87

1.72

2.4

1.6

—

Other headache syndromes

379

1.42

1.71

1.7

2.3

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

3.86

1.71

2.6

1.0

—

Oligomenorrhoea

3.85

1.71

2.8

2.6

—

Congenital ovarian cysts

3.85

1.71

2.2

2.4

—

Other neurological diseases

100

599

1.29

1.71

1.9

2.1

—

Benign neoplasm: Adrenal gland

2.06

1.70

2.2

2.0

—

conjunctival haemorrhage

2.06

1.70

1.1

1.7

—

Diseases of external ear

340

1.44

1.69

2.0

2.1

—

Inflammatory bowel disease, strict (require KELA)

203

1.58

1.67

1.9

2.4

—

Family history of malignant neoplasm

2.18

1.67

4.5

1.3

—

Disorders of synovium and tendon

460

1.35

1.66

1.9

2.3

—

Combinations of oral blood glucose lowering drugs

331

0.57

1.66

2.4

2.2

—

Hypothyroidism, other/unspecified

116

601

1.27

1.66

1.9

2.1

—

Viral encephalitis, not elsewhere classified/unspecified

3.17

1.66

1.2

1.5

—

Burn and corrosion of hip and lower limb, except ankle and foot

3.17

1.66

1.8

1.6

—

Mental and behavioural disorders due to opioids

3.17

1.66

1.2

3.2

—

Allergic conjunctivitis

515

1.35

1.66

1.7

2.2

—

Crohn's disease of large intestine

2.59

1.66

2.4

2.0

—

Other congenital malformations of skin

2.81

1.65

5.4

1.5

—

Other diseases of biliary tract

1.98

1.64

1.9

1.7

—

Decubitus ulcer and pressure area

2.25

1.63

1.6

1.4

—

Coronary atherosclerosis

439

1.31

1.63

1.7

2.2

—

Other and unspecified acquired haemolytic anaemias

3.61

1.62

1.8

1.5

—

Benign neoplasm: Brain, supratentorial

3.59

1.62

1.0

1.6

—

Helminthiases

3.59

1.62

2.0

1.4

—

Granulomatous disorders of skin and subcutaneous tissue

3.58

1.61

2.2

1.4

—

Complications following abortion and ectopic and molar pregnancy

3.58

1.61

2.2

3.1

—

Speech therapy

237

1.52

1.61

2.2

1.9

—

Other noninflammatory disorders of vagina

2.38

1.61

2.5

2.0

—

Mood [affective] disorders

138

714

1.24

1.60

2.3

2.1

—

Other diseases of gallbladder

2.51

1.59

1.4

—

Mood disorders, excluding more controls

126

592

1.25

1.59

2.3

2.1

—

Benign neoplasm: Cerebral meninges

2.00

1.59

2.0

1.8

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

3.01

1.58

4.3

1.4

—

Pacemaker

336

1.41

1.57

1.4

2.0

—

Mood disorders

138

715

1.23

1.57

2.3

2.1

—

Diseases of pulp and periapical tissues and dental caries

322

1.32

1.56

2.1

1.9

—

Symptoms and signs involving the nervous and musculoskeletal systems

611

1.31

1.56

1.8

2.1

—

Crowding of teeth, including avohilmo

2.07

1.55

1.8

2.4

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.28

1.55

2.3

2.8

—

Cardiac arrest

2.30

1.55

1.8

2.1

—

UC patients in KELA-register (code 208), prior to 1994

2.28

1.55

1.4

1.5

—

Bullous disorders

2.28

1.55

1.4

1.5

—

Other coagulation defects

2.28

1.55

2.4

2.0

—

Disorders of psychological development

1.86

1.55

1.9

3.0

—

Nerve, nerve root and plexus disorders

143

699

1.23

1.55

2.1

—

Cirrhosis of liver, NAS

2.11

1.55

1.2

1.7

—

Bell's palsy

1.88

1.54

1.8

2.2

—

Insomnia

700

0.76

1.54

1.4

2.3

—

Perforation of tympanic membrane

1.93

1.54

1.5

2.3

—

Carcinoma in situ of skin

1.98

1.53

2.4

1.5

—

Cholelithiasis, broad definition with cholecystitis

113

598

1.26

1.53

2.2

2.1

—

Retinal vascular occlusion

100

1.80

1.52

1.4

1.7

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

3.35

1.52

5.0

2.1

—

Discitis, unspecified

3.35

1.52

1.2

1.7

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

3.35

1.52

1.4

1.8

—

Systemic sclerosis, icd10

3.35

1.52

1.0

1.5

—

Systemic sclerosis (FG)

3.35

1.52

1.0

1.3

—

Systemic sclerosis

3.35

1.52

1.0

1.4

—

Other disorders of bone density and structure

3.34

1.52

3.0

1.5

—

Pain in thoracic spine

130

1.69

1.52

1.9

2.4

—

Spondyloarthritis

130

1.69

1.52

2.3

2.4

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

108

0.47

1.52

1.9

2.2

—

Contact with other hot fluids

2.60

1.51

1.9

1.7

—

Sleep disorders

714

0.77

1.51

1.4

2.2

—

Dermatophytosis, including avohilmo

559

1.31

1.51

1.7

2.0

—

Malignant neoplasm of endocrine gland

2.60

1.51

4.0

1.3

—

malignant neoplasm of female genital organs

2.02

1.51

1.1

1.3

—

Juvenile arthritis (FINNGEN)

2.86

1.50

1.3

2.8

—

Hypermobility syndrome

2.86

1.50

1.5

2.0

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

2.86

1.50

1.5

—

Benign neoplasm of brain and other parts of central nervous system

2.16

1.50

1.1

1.5

—

Benign lipomatous neoplasm

283

0.56

1.50

1.4

2.1

—

Cerebral palsy and other paralytic syndromes

1.86

1.50

2.2

—

Allergic rhinitis

255

1.47

1.48

1.8

2.5

—

Retinal vascular disorders

101

1.78

1.48

1.4

1.7

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

127

1.65

1.48

3.0

2.8

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

104

553

1.26

1.48

1.8

2.1

—

Artificial opening status

2.44

1.48

2.0

1.6

—

Urinary track infection

231

1.37

1.47

1.8

2.0

—

Peritonsillar abscess

147

1.63

1.47

2.1

2.8

—

Aortic valve malfunction, age under 60 years

1.84

1.45

2.2

2.1

—

Other keratitis

1.84

1.45

2.7

2.3

—

Attention to artificial openings

2.51

1.45

1.7

2.0

—

Impacted maxillary molar

2.50

1.45

5.3

2.7

—

Benign neoplasm of other and unspecified endocrine glands

117

1.71

1.44

2.4

2.1

—

Benign neoplasm: Stomach

1.88

1.44

1.5

1.6

—

Disorders of muscles

1.88

1.44

1.1

2.5

—

Pregnancy with abortive outcome

282

1.33

1.44

1.9

—

Other abnormal immunological findings in serum

3.14

1.44

1.8

—

Other superficial mycoses

3.14

1.44

1.8

1.5

—

Injury of intra-abdominal organs

3.13

1.44

1.4

—

Hepatocellular carcinoma, including Hilmo

3.13

1.44

1.2

1.0

—

Hyperplasia of prostate

238

1.37

1.44

1.5

2.5

—

Other disorders of Eustachian tube

2.74

1.43

1.3

1.6

—

Osteomyelitis

2.04

1.43

1.7

1.6

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

2.04

1.43

1.5

1.7

—

Disorders of lipoprotein metabolism and other lipidaemias

108

524

1.25

1.42

2.1

—

Dermatophytosis

103

1.75

1.40

1.4

2.0

—

Cardiac murmurs and other cardiac sounds

2.09

1.40

1.9

2.9

—

Benign neoplasm of other and ill-defined parts of digestive system

157

1.59

1.40

2.9

1.9

—

Arterial embolism and thrombosis

2.25

1.40

2.1

1.6

—

Anterior Iridocyclitis

173

1.56

1.39

2.7

2.2

—

Oesophagitis

2.42

1.39

1.3

1.7

—

Vulvovaginal ulceration/inflammation in other diseases

2.42

1.39

3.1

2.3

—

Any dementia

277

0.65

1.39

1.3

1.6

—

Laparoscopic right hemicolectomy

2.08

1.38

1.9

1.5

—

Inguinal hernia

429

1.29

1.38

2.3

—

Chronic suppurative otitis media, including avohilmo

2.00

1.38

1.6

—

Unspecified urinary incontinence

2.00

1.38

1.2

1.8

—

Coxarthrosis

332

1.32

1.37

1.8

2.3

—

Other inflammation of eyelid

119

1.68

1.37

4.4

2.0

—

Other and unspecified diseases of blood and blood-forming organs

2.62

1.37

1.2

1.4

—

Post-traumatic wound infection, not elsewhere classified

2.62

1.37

1.3

1.5

—

Orchitis and epididymitis

1.80

1.37

4.3

2.4

—

Spondylosis

445

1.30

1.36

1.8

2.2

—

Assault

104

1.73

1.36

1.9

2.6

—

Need for immunization against other single viral diseases

2.95

1.36

3.0

1.5

—

Placenta praevia

2.95

1.36

1.4

2.6

—

Exclusion endpoint for clefts

2.95

1.36

2.6

2.1

—

Migraine without aura

135

1.63

1.35

1.3

2.7

—

Acne, including avohilmo

121

1.61

1.35

1.5

3.0

—

Amiodarone users

1.76

1.34

1.6

1.7

—

Substance abuse, excluding more controls

478

1.29

1.34

1.7

2.2

—

Hemiplegia

0.00

1.33

0.0

1.5

—

Abnormal findings on examination of urine, without diagnosis

2.15

1.33

2.7

1.5

—

Crohn disease (strict definition, require KELA, min 2 HDR)

2.13

1.33

2.2

2.4

—

Chronic suppurative otitis media

2.13

1.33

1.7

—

Mental and behavioural disorders due to sedatives or hypnotics

2.04

1.32

1.1

2.6

—

Sequelae of infectious and parasitic diseases, including avohilmo

1.97

1.32

1.2

2.0

—

Injuries to the shoulder and upper arm

117

737

1.22

1.32

1.7

2.2

—

Excessive vomiting in pregnancy

0.00

1.32

0.0

2.3

—

Colorectal cancer

138

1.60

1.31

1.4

1.3

—

Antenatal screening

0.49

1.31

2.1

1.9

—

Ganglion

168

1.55

1.31

1.8

2.4

—

Chronic conjunctivitis

2.51

1.30

4.0

1.5

—

Ulcerative enterocolitis

2.51

1.30

3.3

1.5

—

Tinnitus

225

1.47

1.30

1.6

2.2

—

Pneumonia derived septicemia

2.51

1.30

1.7

—

Hydrocele

106

1.70

1.29

3.7

2.2

—

Obsessive-compulsive disorder

2.35

1.29

2.5

2.6

—

Xerosis cutis

2.79

1.28

3.0

1.3

—

Contact with lifting and transmission devices, not elsewhere classified

2.79

1.28

1.0

1.6

—

Allergic contact dermatitis due to drugs in contact with skin

2.79

1.28

4.2

1.4

—

Morphin

2.79

1.28

3.8

1.6

—

Allergic contact dermatitis

1.76

1.28

2.1

—

Moderate visual impairment, binocular

2.78

1.28

1.6

1.4

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

116

621

1.22

1.28

1.9

2.1

—

Contact with heat and hot substances

2.09

1.27

2.0

1.8

—

Crohn disease (strict definition, require KELA)

2.09

1.27

2.2

2.4

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

2.09

1.27

1.0

3.1

—

Ovarian cyst

127

1.49

1.27

1.7

1.9

—

Other and unspecified psoriasis

2.00

1.27

3.3

1.8

—

Other symptoms and signs involving the nervous and musculoskeletal systems

404

1.34

1.27

2.2

—

Rheumatism, unspecified

1.72

1.27

1.6

2.0

—

Benign neoplasm of mouth and pharynx

1.79

1.27

2.1

1.7

—

Type 2 diabetes, definitions combined

126

604

1.21

1.26

2.3

2.1

—

Additional codes for the location of defect, injury or illness

2.05

1.26

2.2

1.4

—

Polycystic ovarian syndrome, broad definition

2.05

1.26

1.6

2.3

—

Acute and subacute iridocyclitis

162

1.54

1.25

2.6

2.2

—

Benign neoplasm of meninges

1.82

1.25

2.0

1.9

—

Episcleritis

2.23

1.24

2.4

1.9

—

Alzheimer’s disease (Late onset), excluding more controls

0.47

1.24

2.0

1.6

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.40

1.24

2.3

1.9

—

Effects of foreign body entering through natural orifice

228

1.45

1.23

1.6

2.5

—

Conductive and sensorineural hearing loss

107

579

1.23

1.9

2.2

—

Adalimumab

1.77

1.22

2.1

2.5

—

Assault by bodily force

1.91

1.22

1.5

2.8

—

Dementia, including avohilmo

345

0.71

1.22

1.8

1.6

—

Erythema multiforme

2.64

1.21

4.6

1.4

—

Follow-up care involving plastic surgery

2.64

1.21

2.0

2.4

—

Foreign body in respiratory tract

2.17

1.21

1.5

1.6

—

Sleep apnoea, including avohilmo

133

670

1.20

1.21

1.6

2.2

—

Postprocedural disorders of nervous system

2.16

1.21

1.3

2.1

—

Speech disturbances, not elsewhere classified

1.80

1.21

1.7

1.5

—

Inflammatory disease of uterus

1.80

1.21

2.4

2.1

—

Alzheimer disease, excluding more controls

123

0.53

1.20

1.7

1.6

—

Emotional disorders starting during childhood or adolecense, excluding more controls

2.33

1.19

2.3

3.6

—

Gingivitis and periodontal diseases

127

544

1.21

1.19

2.0

2.1

—

Other misadventures during surgical and medical care

2.32

1.19

2.8

1.5

—

Other and unspecified erythematous conditions

2.31

1.18

1.2

1.3

—

Melanocytic naevi of other and unspecified parts of face

2.11

1.18

1.1

1.7

—

Psoriasis

264

1.40

1.18

2.5

2.2

—

Intestinal adhesions without obstruction

1.88

1.18

2.1

—

Intracranial injury

604

0.76

1.17

1.8

2.2

—

Dementia

327

0.71

1.17

1.7

1.6

—

Burns and corrosions

125

1.60

1.17

1.7

2.4

—

Sulfonylureas

295

0.67

1.17

1.8

—

Benign neoplasm: Transverse colon

1.70

1.17

1.7

1.8

—

Persons encountering health services in circumstances related to reproduction

414

1.26

1.17

2.4

2.5

—

Superficial injury of hip and thigh

125

1.60

1.17

2.2

1.9

—

Ulcerative colitis (strict definition, require KELA)

141

1.56

1.16

1.8

2.5

—

Malignant neoplasm of colon

1.77

1.16

1.1

1.2

—

L04AC Interleukin inhibitors

2.00

1.16

1.6

2.7

—

Accidents

101

411

1.23

1.16

2.0

2.4

—

Use of levodopa decarbox-comt-inhibitor

0.00

1.16

0.0

1.5

—

Diseases of arteries, arterioles and capillaries

540

1.24

1.15

1.6

2.1

—

Tuberculosis of other organs, strict

2.51

1.15

1.6

1.5

—

Tuberculosis of other organs, strict, including avohilmo

2.51

1.15

1.6

1.5

—

Nonspecific lymphadenitis

2.05

1.15

3.1

2.4

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

2.50

1.15

1.6

1.5

—

Pure hypercholesterolaemia

501

1.23

1.14

2.1

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

134

1.57

1.14

1.9

2.4

—

Benign neoplasm: Caecum

1.69

1.13

1.8

1.6

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

1.69

1.13

2.2

2.4

—

Caries of dentine, including avohilmo

407

1.23

1.13

2.1

1.9

—

Isolated proteinuria

2.34

1.12

3.1

1.5

—

Diseases of pulp and periapical tissues, including avohilmo

133

577

1.19

1.12

2.0

2.1

—

Conductive hearing loss, unspecified

1.90

1.12

1.5

2.1

—

Left bundle-branch block

1.90

1.12

2.4

1.4

—

Colon adenocarcinoma

1.90

1.12

1.2

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

146

1.53

1.12

1.8

2.5

—

Polyarthrosis

172

1.47

1.11

1.5

2.2

—

Atopic dermatitis

419

1.27

1.11

2.4

2.3

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

1.96

1.11

2.2

2.8

—

Dental caries, including avohilmo

372

1.24

1.11

2.1

1.9

—

Behavioural syndromes associated with physiological disturbances and physical factors

737

0.82

1.11

1.6

2.2

—

Congenital malformations of the circulatory system

131

1.56

1.11

1.8

2.4

—

Fracture of foot, except ankle

217

1.43

1.10

1.5

2.4

—

Arthropathies in other diseases classified elsewhere

2.26

1.10

1.4

1.2

—

Polyarthritis, unspecified

2.26

1.10

2.4

1.9

—

Helminthiases, including avohilmo

2.26

1.10

1.7

2.2

—

Desensitization to allergens

2.26

1.10

1.4

2.6

—

Malignant neoplasm of corpus uteri

2.26

1.10

1.1

1.2

—

Infections with a predominantly sexual mode of transmission

225

1.42

1.10

2.9

2.4

—

Insulin, intermediate and long-acting

553

1.26

1.10

2.1

2.2

—

Pain associated with micturition

1.67

1.10

4.3

1.9

—

Injuries to the hip and thigh

442

1.28

1.10

1.9

2.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

296

0.67

1.09

1.1

2.1

—

Complications of genitourinary prosthetic devices, implants and grafts

2.39

1.09

1.2

1.4

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

2.39

1.09

2.2

2.6

—

Flat foot [pes planus] (acquired)

1.73

1.08

1.9

2.1

—

Benign thyroid growths and nodules

283

0.66

1.08

1.4

1.9

—

Dizziness and giddiness

627

1.22

1.08

1.6

2.2

—

Carcinoma in situ of colon

2.19

1.08

1.9

1.5

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

2.19

1.08

1.3

2.6

—

Nummular dermatitis

1.87

1.07

2.1

1.9

—

Soft tissue disorders related to use, overuse and pressure

261

1.38

1.07

1.4

2.4

—

Glaucoma suspect

362

0.69

1.07

2.0

1.9

—

Other disorders starting during childhood or adolecense, excluding more controls

2.16

1.06

1.9

3.3

—

Poisoning by drugs, medicaments and biological substances

194

1.44

1.06

1.3

2.5

—

Psoriasis vulgaris

153

1.50

1.06

2.9

2.3

—

Burns and corrosions of external body surface, specified by site

105

1.62

1.05

1.8

2.5

—

Giant cell arteritis

2.13

1.05

3.3

1.3

—

Monoarthritis, not elsewhere classified

2.13

1.05

1.6

2.2

—

Trigeminal neuralgia

2.12

1.05

1.6

2.1

—

Cholelithiasis

104

589

1.20

1.05

2.2

2.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

149

1.50

1.04

1.8

2.5

—

All anxiety disorders

468

1.24

1.04

1.8

2.5

—

Other and specified injuries of hip and thigh

2.28

1.03

1.2

1.5

—

Hypoparathyroidism

2.28

1.03

1.2

1.3

—

Type 1 diabetes

220

1.41

1.03

1.4

2.4

—

Glaucoma secondary to other eye disorders

2.06

1.03

3.4

1.6

—

Benign neoplasm: Skin of trunk

2.06

1.03

2.1

1.4

—

Sequelae of infectious and parasitic diseases

1.84

1.02

1.2

2.1

—

Diseases of the myoneural junction and muscle

106

1.61

1.02

1.4

1.9

—

Foreign body on external eye

138

1.52

1.02

1.7

2.7

—

Dental pulpitis, including avohilmo

677

0.82

1.02

2.0

2.3

—

Nontoxic goitre/thyroid nodule

263

0.65

1.01

1.4

1.8

—

Gonarthrosis

376

1.23

1.00

1.7

2.3

—

Other ulcerative colitis

1.88

1.00

2.6

1.9

—

Duodenal ulcer

1.77

1.00

1.5

1.9

—

Papulosquamous disorders

386

1.30

1.00

2.3

2.2

—

Malignant neoplasm of corpus uteri, including Hilmo

2.00

1.00

1.1

1.2

—

Presbyopia

1.71

0.98

1.9

2.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

1.84

0.98

4.7

2.1

—

Anxiety (asthma-related co-morbidities)

455

1.24

0.98

1.7

2.4

—

Heart failure and hypertrophic cardiomyopathy

2.18

0.98

1.4

—

Left hemicolectomy

2.18

0.98

1.2

1.4

—

Other bullous disorders

2.18

0.98

1.4

—

Other external causes of accidental injury

411

1.21

0.98

1.9

2.4

—

Dementia due to Parkinson's disease

0.00

0.98

0.0

1.4

—

Acute pancreatitis (for exclusion)

181

1.44

0.98

2.4

2.0

—

Vascular diseases of the intestine

0.00

0.97

0.0

1.7

—

Dissection of aorta

0.00

0.97

0.0

2.0

—

Glucosamine medication

385

0.75

0.97

1.7

1.8

—

Neovascular glaucoma

1.95

0.97

3.4

1.6

—

Disorders of the thyroid gland

120

660

1.18

0.96

1.9

2.2

—

Chondropathies

132

1.52

0.96

2.6

2.2

—

Cysts of oral region, not elsewhere classified

1.86

0.96

2.0

1.6

—

Other diseases of blood and blood-forming organs

1.85

0.96

3.4

1.6

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

124

625

1.18

0.96

2.4

2.1

—

Cholecystitis

124

1.53

0.96

2.5

1.9

—

Arthropathies

111

471

1.19

0.96

2.3

—

Endometriosis of ovary

109

1.56

0.96

1.3

1.9

—

Any dementia, excluding more controls

244

0.70

0.96

1.4

1.7

—

Other congenital malformations of the digestive system, including avohilmo

1.79

0.95

1.2

1.8

—

Fracture of femur

217

1.37

0.95

1.9

1.7

—

Pleural plaque

1.69

0.95

1.8

1.5

—

Other abnormal uterine and vaginal bleeding

112

1.48

0.94

1.7

1.9

—

Tumor necrosis factor alpha inhibitors

133

1.51

0.94

1.8

2.5

—

Follicular cysts of skin and subcutaneous tissue

166

1.45

0.94

2.4

2.2

—

Peripheral artery disease

349

1.27

0.93

1.5

1.9

—

Symptoms and signs involving emotional state

2.23

0.93

1.5

—

Chondrocostal junction syndrome [Tietze]

2.23

0.93

2.8

1.3

—

Falls/tendency to fall

136

584

1.17

0.93

1.8

2.3

—

Single delivery by forceps and vacuum extractor

0.47

0.93

4.4

1.9

—

Type 2 diabetes, definitions combined, including avohilmo

125

617

1.17

0.92

2.4

2.1

—

Other antidepressants

132

577

1.17

0.92

2.0

2.2

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1.73

0.92

1.8

1.4

—

Inflammatory diseases of female pelvic organs

345

1.25

0.92

1.7

1.9

—

Motorcycle rider injured in other and unspecified transport accidents

1.82

0.92

2.0

3.1

—

Disturbances of skin sensation

226

1.37

0.92

1.7

2.1

—

Rheumatic fever incl heart disease

2.15

0.91

1.0

1.4

—

Pneumococcal septicemia

2.15

0.91

1.7

1.6

—

Malignant neoplasm of thyroid gland, including Hilmo

2.14

0.91

3.7

1.3

—

Other and unspecified visual disturbances

1.67

0.91

1.0

1.9

—

2.14

0.91

1.0

1.5

—

Atrophic disorders of skin

110

1.55

0.90

3.0

2.0

—

Melanocytic naevi of trunk

102

1.57

0.90

1.7

2.2

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

151

1.46

0.90

1.8

2.5

—

Carcinoma in situ of skin of upper limb, including shoulder

2.08

0.89

1.3

1.4

—

Pregnancy hypertension

270

0.69

0.89

1.1

2.1

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

2.07

0.89

1.3

1.4

—

Disorder of external ear, unspecified

2.07

0.89

2.7

1.6

—

Other erythematous conditions

2.07

0.89

1.2

1.3

—

Hyperfunction of pituitary gland

2.07

0.89

4.3

1.9

—

Impetigo

2.07

0.89

1.8

2.1

—

Iridocyclitis

202

1.39

0.89

2.6

2.2

—

Hypertrophic cardiomyopathy

1.91

0.88

1.3

1.6

—

Dislocation, sprain and strain of joints and ligaments at neck level

127

1.50

0.88

1.6

2.6

—

Other congenital malformations of the digestive system

1.89

0.88

1.3

1.9

—

Atopic dermatitis, strict definition

248

1.34

0.88

1.8

2.5

—

Poisoning by medicine

177

1.41

0.88

1.3

2.5

—

Type 2 diabetes, strict (exclude DM1)

124

619

1.17

0.88

2.4

2.1

—

Gestational [pregnancy-induced] hypertension

155

0.58

0.88

1.0

2.1

—

Chronic diseases of tonsils and adenoids

463

1.20

0.87

2.4

2.5

—

Other intracranial haemorrhages

2.00

0.87

1.5

1.4

—

Adhesive capsulitis of shoulder

144

1.46

0.87

2.2

2.4

—

Uterine polyps

117

1.40

0.86

1.6

1.9

—

Other follicular disorders

1.72

0.86

2.0

2.1

—

Lesion of lateral popliteal nerve

1.82

0.86

1.3

1.9

—

Scleritis and episcleritis

1.82

0.85

2.4

1.9

—

Nail disorders

1.67

0.85

1.4

2.2

—

Pneumonitis due to solids and liquids

1.67

0.85

1.0

1.7

—

Lichen sclerosus et atrophicus

1.67

0.85

3.6

1.9

—

Retinal detachments and breaks

361

1.27

0.85

1.8

1.9

—

Injuries to the ankle and foot

663

1.18

0.84

1.7

2.3

—

Abnormalities of gait and mobility

112

1.52

0.84

1.0

1.6

—

Nontoxic multinodular goitre

167

0.60

0.84

1.1

1.8

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

112

1.52

0.84

1.0

2.3

—

Carcinoma in situ of other and unspecified digestive organs

1.78

0.84

1.8

1.6

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

203

0.72

0.83

2.1

—

Invasive ventilation

1.76

0.83

1.3

2.0

—

Sensorineural hearing loss

100

566

1.18

0.83

1.9

2.2

—

Presbycusis

103

1.54

0.83

1.1

1.5

—

Mental and behavioural disorders due to psychoactive substance use

579

1.20

0.83

1.7

2.3

—

Lumbar disc prolapse

494

1.20

0.83

1.8

2.2

—

Unspecified lump in breast

112

0.54

0.83

2.3

1.8

—

Disorders of speech understanding and production

1.75

0.82

1.6

2.6

—

Substance abuse

571

1.20

0.82

1.7

2.3

—

Traumatic subarachnoid haemorrhage

1.88

0.82

1.2

1.9

—

Melanocytic naevi of lower limb, including hip

1.88

0.82

2.2

1.9

—

Other CVD (FINNGEN)

1.59

0.81

1.8

2.1

—

Myopia

105

1.53

0.81

1.6

2.5

—

Melanocytic naevi

284

1.30

0.81

1.9

2.2

—

Other disorders of cornea

1.61

0.81

1.0

2.2

—

Obesity

637

0.81

1.8

2.3

—

Emotional disorders starting during childhood or adolescence

1.86

0.81

2.3

3.1

—

Diabetes, insulin treatment (Kela reimbursement)

132

683

1.15

0.80

2.3

2.1

—

Hyperkalaemia

1.70

0.80

2.8

1.5

—

Visual impairment including blindness (binocular or monocular)

1.70

0.80

1.9

1.4

—

Infections with a predominantly sexual mode of transmission, including avohilmo

284

1.29

0.80

2.6

2.4

—

Psychiatric diseases

127

551

1.15

0.80

2.1

2.2

—

Abnormal serum enzyme levels

309

1.28

0.79

2.2

2.1

—

Other and unspecified mononeuropathies, also in other diseases

0.00

0.79

0.0

1.4

—

Barrett oesophagus

1.82

0.79

1.0

2.0

—

Other orthopaedic follow-up care

1.82

0.79

2.5

1.5

—

MS-disease / Multiple Sclerosis

1.82

0.79

1.0

1.8

—

Meralgia paraesthetica

0.00

0.79

0.0

2.1

—

Medical abortion

273

1.23

0.79

1.8

1.9

—

Circumscribed brain atrophy

0.00

0.78

0.0

1.3

—

Other and unspecified intracranial injuries

0.00

0.78

0.0

1.3

—

Other arthrosis

376

1.21

0.78

1.5

2.3

—

Other disorders of the genitourinary system

1.53

0.78

1.7

—

Other and unspecified rosacea

1.62

0.78

1.7

2.0

—

Open wound of ankle and foot

1.56

0.78

1.8

2.8

—

Toxic effects of substances chiefly nonmedicinal as to source

1.56

0.78

1.9

2.3

—

Acute and transient psychotic disorders

0.52

0.78

1.0

2.4

—

Congenital malformations of heart and great arteries

119

1.47

0.78

1.7

2.5

—

Other degenerative diseases of the basal ganglia

0.00

0.77

0.0

1.4

—

Rotator cuff syndrome

450

1.19

0.77

1.7

2.3

—

Other and unspecified mental retardation

0.00

0.77

0.0

2.1

—

Chronic periodontitis, complicated

613

1.19

0.77

2.3

2.1

—

Primary gonarthrosis, bilateral

499

0.80

0.77

1.6

2.1

—

Polyp of the female genital tract

121

1.36

0.77

1.5

1.9

—

Transport accidents

379

1.23

0.77

2.2

2.4

—

Diabetes mellitus in pregnancy

127

0.65

0.77

1.8

2.3

—

Injuries to the neck

191

1.36

0.76

1.6

2.4

—

Occupational exposure to risk-factors

1.77

0.76

4.5

1.4

—

Corneal ulcer

157

1.40

0.76

2.0

2.3

—

Type 1 diabetes, wide definition, subgroup 1

174

1.38

0.76

1.5

2.3

—

Aortic aneurysm

213

1.34

0.75

1.8

2.0

—

malignant neoplasm of male genital organs, including Hilmo

129

1.35

0.75

2.7

1.4

—

LSIL lesion of the cervix uteri

1.70

0.75

3.4

2.2

—

Other/unspecified synovitis and tenosynovitis

1.52

0.75

2.5

2.4

—

Extrapyramidal and movement disorders

393

0.76

0.75

1.4

2.0

—

LSIL lesion of the cervix uteri, vagina or vulva

1.60

0.74

3.1

2.2

—

Acute pancreatitis

192

1.36

0.74

2.4

2.2

—

Other maltreatment syndromes

2.09

0.74

1.2

2.7

—

Endometriosis ASRM stages 3,4

141

1.42

0.74

1.3

1.9

—

Obesity and other hyperalimentation

639

0.82

0.74

1.8

2.3

—

Ingrowing nail

1.84

0.73

1.7

1.6

—

Specific development disorders of speech and language

1.64

0.73

1.6

3.0

—

Postmenopausal atrophic vaginitis

108

1.36

0.73

1.7

1.9

—

Other disorders of bladder

108

1.48

0.73

1.1

2.1

—

Colorectal adenocarcinoma

123

1.44

0.73

1.1

1.3

—

Other CVD

167

1.38

0.73

1.8

1.7

—

Benign neoplasm: Anus and anal canal

2.00

0.72

1.0

1.4

—

Bacterial meningitis

2.00

0.72

2.2

1.5

—

Contact with sharp glass

2.00

0.72

2.2

—

Inflammatory disorders of breast

2.00

0.72

1.0

2.1

—

Unspecified/other endometriosis

1.81

0.72

1.1

2.1

—

Post-traumatic stress disorder

1.80

0.72

1.6

2.3

—

Sleep disorders (combined)

141

649

1.13

0.72

1.7

2.3

—

Endometriosis diagnosis and infertility diagnosis occurring together

1.61

0.72

1.7

2.2

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

1.67

0.72

1.3

1.5

—

Primary coxarthrosis, bilateral

290

1.28

0.72

1.7

1.9

—

Cyst of kidney

1.62

0.71

2.5

1.6

—

Ulcerative rectosigmoiditis

1.62

0.71

2.6

2.3

—

Cervicocranial syndrome

1.58

0.71

1.1

2.1

—

Thyroiditis, ILD-related definition

1.58

0.71

1.4

2.1

—

Benign neoplasm of urinary organs

1.75

0.71

1.1

1.4

—

Migraine

351

1.22

0.70

1.7

2.5

—

Peripheral retinal degeneration

1.93

0.70

1.4

1.3

—

Other and unspecified corneal deformities and disorders

1.93

0.70

1.0

1.4

—

Migraine with aura and triptan purchases

109

1.47

0.70

1.9

2.3

—

Hypertensive Renal Disease

1.93

0.70

1.6

1.5

—

Other obstetric trauma

1.93

0.70

3.2

2.5

—

Inflammatory disease of cervix uteri

1.92

0.70

1.4

2.0

—

Other disorders starting during childhood or adolescence

1.73

0.70

1.9

3.0

—

Recurrent or chronic depression

275

1.24

0.70

1.7

2.4

—

Diabetes medication

132

679

1.13

0.70

2.2

2.1

—

Mixed conductive and sensorineural hearing loss

101

1.49

0.70

1.8

2.1

—

Thoracic aortic aneurysm

143

1.40

0.70

2.0

—

Special screening examination for neoplasms

1.71

0.70

1.1

2.1

—

Mandibular retrognathia

1.70

0.69

2.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

118

1.44

0.69

1.8

2.4

—

Leisure time condition

157

0.64

0.68

1.0

2.4

—

Benign neoplasm of male genital organs

1.86

0.68

4.8

1.6

—

Ulcerative ileocolitis

1.85

0.68

1.0

1.4

—

Intrahepatic Cholestasis of Pregnancy (ICP)

1.85

0.68

1.4

2.2

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

1.85

0.68

1.4

2.9

—

Foreign body entering into or through eye or natural orifice

1.56

0.68

1.3

2.2

—

Fibromyalgia

1.64

0.68

1.1

2.2

—

Examination and encounter for administrative purposes

1.67

0.68

2.1

1.9

—

Other/unspecified enthesopathies, not elsewhere classified

1.60

0.68

1.2

2.2

—

Lesion of ulnar nerve

110

1.46

0.68

1.2

2.2

—

Depression or dysthymia

417

1.17

0.67

2.3

2.1

—

Seborrhoeic keratosis

222

1.31

0.67

1.4

1.9

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

311

1.25

0.67

1.8

2.2

—

Panic disorder

102

1.47

0.67

1.6

2.7

—

Sequelae of cerebrovascular disease

311

1.24

0.67

1.5

1.9

—

Non-small cell lung cancer, squamous, helper endpoint

1.63

0.66

1.1

1.4

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1.63

0.66

1.3

2.2

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

343

1.24

0.66

1.9

2.6

—

Lichen simplex chronicus

1.79

0.66

1.6

1.5

—

Leiomyoma of uterus

275

1.20

0.65

2.0

1.8

—

Postprocedural musculoskeletal disorders, not elsewhere classified

1.61

0.65

1.3

1.4

—

Other female pelvic inflammatory diseases

103

1.46

0.64

1.1

2.1

—

Varicose veins

456

1.18

0.64

2.2

1.9

—

Gestational diabetes (for exclusion)

155

0.71

0.64

1.7

2.1

—

Hypogonadotropic hypogonadism

1.73

0.64

3.6

2.4

—

Fall involving bed

1.73

0.64

2.0

1.4

—

Temporal arteritis

1.73

0.64

3.0

1.3

—

Other and unspecified injuries of ankle and foot

1.73

0.64

1.0

1.8

—

Schizophrenia

130

0.61

0.63

1.1

2.7

—

Strabismus

242

1.28

0.62

1.7

2.3

—

Degeneration of macula and posterior pole

389

1.19

0.62

1.8

—

Primary hyperparathyroidism

1.52

0.62

2.3

1.9

—

Infective dermatitis

1.52

0.62

1.5

2.1

—

False labour

125

0.69

0.62

1.2

2.3

—

Other and unspecified vascular occlusions

1.52

0.62

1.6

—

Impingement syndrome of shoulder

243

1.28

0.62

2.4

—

Superficial injury of ankle and foot

104

1.44

0.62

1.6

2.7

—

Type 1 diabetes, wide definition

190

1.31

0.62

1.5

2.3

—

Supervision of normal pregnancy

0.65

0.62

4.0

2.0

—

Pemphigoid

1.67

0.61

1.2

1.5

—

Other disorders of pigmentation

1.67

0.61

1.4

1.2

—

Amblyopia ex anopsia

1.67

0.61

1.6

1.7

—

Convalescence

1.67

0.61

1.2

2.1

—

Operations 2 for CAVS

260

1.26

0.61

1.6

1.8

—

Calcific aortic valvular stenosis, diagnosis (helper)

260

1.26

0.61

1.6

1.8

—

Focal brain injury

1.60

0.61

1.0

2.6

—

Other contact dermatitis

1.60

0.61

3.4

2.1

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

1.60

0.61

1.0

1.3

—

Crossbite

1.59

0.61

1.7

2.0

—

Triptan medication for migraine, single purchase ok

538

0.86

0.60

1.9

2.4

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

538

0.86

0.60

1.9

2.4

—

Communicating hydrocephalus

0.00

0.60

0.0

1.4

—

Embedded teeth, including avohilmo

1.57

0.60

4.2

2.2

—

Malignant neoplasm of rectum

1.57

0.60

1.9

1.4

—

Stroke, excluding SAH

472

1.16

0.60

1.6

2.0

—

Orthopaedic devices associated with adverse incidents

0.00

0.60

0.0

1.5

—

Dementia due to Parkinsons disease, excluding more controls

0.00

0.60

0.0

1.5

—

Contact with sharp object, undetermined intent

0.00

0.60

0.0

1.5

—

Benign neoplasm of thyroid gland

0.00

0.60

0.0

1.4

—

Golimumab

0.00

0.60

0.0

1.5

—

Calcific aortic valvular stenosis

261

1.25

0.60

1.6

1.8

—

Calcific aortic valvular stenosis, operated

261

1.25

0.60

1.6

1.8

—

Rosacea

105

1.43

0.60

1.5

1.9

—

0.00

0.60

0.0

2.6

—

Sequelae of injuries of lower limb

1.50

0.59

1.6

2.5

—

Anomalies of dental arch relationship, including avohilmo

157

1.32

0.59

3.2

2.5

—

Calcific aortic valvular stenosis, including rheumatic fever

261

1.25

0.59

1.6

1.8

—

Inguinal hernia, bilateral

1.44

0.59

2.6

2.1

—

Inguinal or femoral hernia, bilateral

1.44

0.59

2.6

2.1

—

Nonorganic sleeping disorders, excluding more controls

157

1.34

0.58

1.4

2.5

—

Glucagon-like peptide-1 (GLP-1) analogues

344

0.78

0.58

1.6

2.4

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

344

0.78

0.58

1.6

2.4

—

Arthrosis

399

1.15

0.58

1.9

2.3

—

Other bursopathies

114

1.40

0.58

1.6

2.3

—

Myocardial infarction

374

1.18

0.58

1.3

2.2

—

Patent foramen ovale

0.00

0.58

0.0

1.9

—

Dronedarone medication

0.00

0.58

0.0

1.3

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.58

0.0

1.6

—

Dislocation, sprain and strain of joints and ligaments of elbow

1.51

0.58

2.4

2.1

—

Postpartum haemorrhage due to retained placenta

1.51

0.58

2.6

2.5

—

Vitamin deficiency, wide

1.72

0.57

1.0

1.5

—

Vitamin deficiency

1.72

0.57

1.0

1.5

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

115

0.61

0.57

1.7

2.3

—

Deforming dorsopathies

255

1.25

0.57

1.6

2.5

—

Other hearing loss

247

1.26

0.57

1.4

1.9

—

Biguanides

663

0.88

0.56

1.9

2.1

—

Chronic iridocyclitis

1.67

0.56

2.8

1.5

—

Other obstructive and reflux uropathy

1.67

0.56

1.0

2.0

—

Thyrotoxicosis with diffuse goitre

115

1.39

0.56

1.4

2.1

—

Striking against or struck by other objects

337

1.22

0.56

1.8

2.6

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

1.51

0.56

2.2

1.7

—

Macular hole

1.46

0.56

1.4

1.6

—

Injury of nerves at wrist and hand level

1.62

0.55

2.3

2.2

—

Other and unspecified mood [affective] disorders

1.62

0.55

1.0

2.3

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Aspergillus sp Ab [Presence] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS